A , B , C , D , E , F , G , H , I , J , K , L , M , N , O , P , Q , R , S , T , U , V , W , X , Y , Z
Kürzel | Test | Einh. | Normalbereich | Hinweis | ||
11DCORT | 11-Deoxycortisol | ng/ml | 0.000 | - | 5.000 | MATERIAL: Serum, METHODE: |
17KETO | 17-Ketosteroide i.24h H. | mg/24h | 6.000 | - | 15.000 | MATERIAL: 24h-Sammelharn, METHODE: CMIA |
17OHPREG | 17-OH Pregnenolon | µg/l | 0.000 | - | 2.500 | MATERIAL: Serum, |
17OHPROG | 17-OH Progesteron | ng/ml | - | MATERIAL: Serum, METHODE: ELISA | ||
21DCORT | 21-Deoxycortisol | ug/l | 0.00 | - | 0.30 | MATERIAL: Serum |
4-AA | 4-Aminoantipyrin | mg/l | - | MATERIAL: Serum, Methode: LC-MS | ||
4-MAA | 4-Methylaminoantipyrin | mg/l | - | MATERIAL: Serum, Methode: LC-MS | ||
5FU_TOXGEN | 5-FU Toxizität (DPYD) | - | MATERIAL: EDTA; Methode: Gentest | |||
5HIES | 5-HIES i.24h H. | mg/24h | 2.00 | - | 8.00 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
6-MMP | 6-Methylmercaptopurin | pmol/0.2ml | - | MATERIAL: EDTA- oder Li-Heparin-Plasma, METHODE: LC-MS | ||
6-MP | 6-Mercaptopurin | ug/l | - | MATERIAL: Serum gefroren, METHODE: LC-MS | ||
6-TGN | 6-Thioguanin-Nucleotide | pmol/0.2ml | - | MATERIAL: EDTA- oder Li-Heparin-Plasma, METHODE: LC-MS | ||
8-OH-DGU | 8-OH-Desoxyguanosin/g Krea i.H. | ug/g Kreat | 2.340 | - | 16.120 | MATERIAL: Harn; Methode: EIA |
A1GLY | A1 saures Glycoprotein | mg/dl | 50.00 | - | 120.00 | MATERIAL: Serum, METHODE: turbidimetrisch |
A1MGU | Alpha-1-Mikroglobulin i.H. | mg/dl | 0.00 | - | 2.00 | MATERIAL: Spontanharn, METHODE: Turbitimetrisch |
A1MGUKR | Alpha-1-Mikroglob. /g Krea i.H. | mg/g Krea. | 0.00 | - | 14.00 | MATERIAL: Spontanharn, METHODE: Turbitimetrisch |
A2MG | Alpha-2-Makroglobulin | g/l | 1.300 | - | 3.000 | MATERIAL: Serum, METHODE: turbidimetrisch |
AAKIFT | ANA IFT | Titer | < | 160.0 | MATERIAL: Serum, METHODE: Immunfluoreszenz | |
ABCAND | Candida im Abstrich | - | MATERIAL: Abstrich, METHODE: Kultur | |||
ABPATH | Abstrich auf pathogene Keime | - | MATERIAL: Abstrich, METHODE: Kultur | |||
AC | Aceton i.H. | - | MATERIAL: Spontanharn, METHODE: STIX | |||
ACA | Centromer AK | - | MATERIAL: Serum; METHODE: IFT/Blot | |||
ACE | ACE (Angiot.Conv.Enzyme) | U/l | 20.0 | - | 70.0 | MATERIAL: Serum, METHODE: photometrisch |
ACLAA | Cardiolipin-AK IgA | U/ml | 0.00 | - | 15.00 | MATERIAL: Serum, METHODE: ELISA |
ACLAG | Cardiolipin-AK IgG | U/ml | 0.00 | - | 12.00 | MATERIAL: Serum, METHODE: ELISA |
ACLAM | Cardiolipin-AK IgM | U/ml | 0.00 | - | 12.00 | MATERIAL: Serum, METHODE: ELISA |
ACRAK | Acetylcholinrezeptor-AK | nmol/l | 0.000 | - | 0.400 | MATERIAL: Serum |
ACTABS | Aktivierte T-Zellen absolut | /mm3 | 0.0 | - | 100.0 | MATERIAL: EDTA, METHODE: Flow cytometrie |
ACTH | ACTH | pg/ml | 7.200 | - | 63.300 | MATERIAL: EDTA, METHODE: CLIA |
ACTREL | Aktivierte T-Zellen relativ | % | 2.0 | - | 12.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |
ADALIMU | Adalimumab | ug/ml | 5.000 | - | 12.000 | MATERIAL: Serum |
ADALIMUAK | Adalimumab Anti-Drug-Antikörper | ng/ml | 0.00 | - | 10.00 | MATERIAL: Serum |
ADAMTS13 | ADAMTS13-Aktivität | % | - | MATERIAL: Citrat, METHODE: FRET-Assay | ||
ADENOPCR | Adenovirus (DNA) PCR | - | MATERIAL: Abstrich,Harn,Stuhl, METHODE: PCR | |||
ADG | Adenovirus-IgG | U/ml | < | 22.000 | MATERIAL: Serum, METHODE: ELISA | |
ADH | ADH/Vasopressin | - | MATERIAL: Serum | |||
ADHU | ADH/Vasopressin i.H. | pmol/l | 0.93 | - | 104.00 | MATERIAL: Spontanharn |
ADINEKTIN | Adiponektin | µg/l | - | MATERIAL: Serum | ||
AD-KBR | Adenovirus KBR | Titer | 0.0 | - | 40.0 | MATERIAL: Serum, METHODE: KBR |
ADM | Adenovirus-IgM | RATIO | < | 1.100 | MATERIAL: Serum, METHODE: ELISA | |
ADMA | Dimethylarginin asymmetrisches | ug/l | 50.00 | - | 110.00 | MATERIAL: Serum gefroren METHODE: LCMS |
ADN | Antistrepto DNase B | U/ml | 0.0 | - | 187.0 | MATERIAL: Serum, |
ADRH | Adrenalin i.24h H. | ug/24h | 4.00 | - | 20.00 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
ADRS | Adrenalin (P) | pg/ml | 30.0 | - | 90.0 | MATERIAL: EDTA Plasma, METHODE: HPLC |
AFP | AFP (A-1-Fetoprotein) | ng/ml | 0.00 | - | 15.00 | MATERIAL: Serum, METHODE: CMIA |
AKDIFF | Antikörper-Differenzierung | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
AKSUCH | Antikörper-Suchtest (ICT) | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
AL | Aluminium im Serum | ug/l | 0.00 | - | 10.00 | MATERIAL: Serum, METHODE: AAS |
ALB | Albumin | % | 55.80 | - | 66.10 | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese |
ALBENDAZOL | Albendazol | ug/ml | - | MATERIAL: Serum, METHODE: HPLC | ||
ALBKREAQU | Albumin Kreatinin Ratio i.H. | mg/g | 0.00 | - | 30.00 | |
ALBU | Albumin | mg/dl | 3500.0 | - | 5500.0 | MATERIAL: Serum, METHODE: photometrisch |
ALBUH | Albumin i.H. | mg/l | 0.00 | - | 20.00 | MATERIAL: Spontanharn, METHODE: turbidimetrisch |
ALBUP | Albumin im Punktat | mg/dl | - | MATERIAL: Punktat, METHODE: photometrisch | ||
ALD | Aldolase | U/l | 0.000 | - | 7.600 | MATERIAL: Serum, METHODE: photometrisch |
ALDOS | Aldosteron | ng/l | 25.600 | - | 445.000 | MATERIAL: Serum, METHODE: CLIA |
ALDOSH | Aldosteron /g Krea i.H. | ug/g Krea | 1.500 | - | 20.000 | MATERIAL: Spontanharn + Borsäure angesäuerter Harn |
ALDOSLIEG | Aldosteron im Liegen | ng/l | 19.700 | - | 260.000 | MATERIAL: Serum, METHODE: CLIA |
ALDRENQ | Aldosteron-Renin-Quotient | - | ||||
ALDRENQL | Aldost.-Renin-Quotient liegend | - | ||||
ALFAA | Alpha 1 | % | 2.90 | - | 4.90 | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese |
ALFAAA | Alpha 1 | g/dl | 0.210 | - | 0.350 | |
ALFAB | Alpha 2 | % | 7.10 | - | 11.80 | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese |
ALFABA | Alpha 2 | g/dl | 0.510 | - | 0.850 | |
ALH | Aluminium im 24h H. | ug/24h | 0.00 | - | 60.00 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
ALPHAGLA | Alpha-Galaktosidase A i.Leuko | nmol/h/mg | 14.000 | - | 72.600 | MATERIAL: EDTA; METHODE: CMIA |
ALPRAZOLAM | Alprazolam | ug/l | 5.00 | - | 50.00 | MATERIAL: Serum, METHODE: LC-MS |
ALUKR | Aluminium /g Krea i.H. | ug/g Krea | 0.00 | - | 60.00 | MATERIAL: Spontanharn, METHODE: AAS/Clia |
AMA | AMA | Titer | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | ||
AMAM2 | AMA-M2 | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
AMH | AMH (Anti Müller Hormon) | pmol/l | - | MATERIAL: Serum, METHODE: EIA | ||
AMINOS | Aminosäuren im EDTA-Plasma | - | MATERIAL: EDTA-Plasma Methode: Chromatographie | |||
AMINOU | Aminosäuren i.H. | - | MATERIAL: Spontanharn, Methode: | |||
AMIO | Amiodaron | ug/l | 1000.0 | - | 2500.0 | MATERIAL: Serum, METHODE: HPLC |
AMISULPRID | Amisulprid | ng/ml | 100.00 | - | 320.00 | MATERIAL: Serum, METHODE: |
AMITRYPT | Amitriptylin + Nortriptylin | ug/l | 80.00 | - | 200.00 | MATERIAL: Serum, METHODE: LC-MS |
AMPH | Amphetamine i.H. | ng/ml | 0.0 | - | 1000.0 | MATERIAL: Spontanharn, METHODE: EMIT |
AMPS | Amphetamine (S) | µg/l | - | MATERIAL: Serum, METHODE: FPIA | ||
AMYLH | Amylase i.H. | U/l | 16.0 | - | 491.0 | MATERIAL: Spontanharn, METHODE: photometrisch |
AMYLMACRO | Amylase Makro | - | MATERIAL: Serum, METHODE: Isoenzymelphor | |||
AMYLOIDA | Amyloid A Protein | mg/l | 0.00 | - | 6.30 | MATERIAL: Serum, |
AMYLOIDß42 | Amyloid ß-42 Protein | mg/l | 0.00 | - | 6.30 | MATERIAL: Serum, |
AMYLPANK | Amylase Pankreas | U/l | 13.0 | - | 53.0 | MATERIAL: Serum, METHODE: photometrisch |
AMYLPAROT | Amylase Parotis | U/l | 18.0 | - | 65.0 | MATERIAL: Serum, METHODE: Isoenzymelphor |
AMYLS | Amylase gesamt | U/l | 5.0 | - | 160.0 | MATERIAL: Serum, METHODE: photometrisch |
ANA | ANA Screening | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
ANAMUSTER | ANA Fluoreszenzmuster | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
ANCA | ANCA | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
ANDRO | Androstendion | ng/ml | 0.300 | - | 3.700 | MATERIAL: Serum, METHODE: ELISA |
ANTIB1 | Antibiogramm zu Erreger 1 | - | MATERIAL: Abstrich, METHODE: Kultur | |||
ANTIB2 | Antibiogramm zu Erreger 2 | - | MATERIAL: Abstrich, METHODE: Kultur | |||
ANTIB3 | Antibiogramm zu Erreger 3 | - | MATERIAL: Abstrich, METHODE: Kultur | |||
ANTIOX | Antioxidantienstatus | - | Material: Serum+EDTA Methode:diverse | |||
AP | Alk.Phosphatase | U/l | 40.0 | - | 150.0 | MATERIAL: Serum, METHODE: photometrisch |
AP50 | AP50/Altern.Pathway | % | 66.0 | - | 130.0 | MATERIAL: Serum, |
APC | APC Resistenz | % | 0.00 | - | 10.00 | MATERIAL: Citratplasma; METHODE:chromogenes Substrat |
APCD | Faktor V-Mutation | - | MATERIAL: EDTA, METHODE: DNA-Analyse | |||
APISO_RES | Alk.Phosphatase Isoenzyme | - | MATERIAL: Serum/Vollblut, METHODE: IFE | |||
APK | Alk.Phos.Isoenzym Knochen | % | 7.00 | - | 60.00 | MATERIAL: Serum/Vollblut |
APL | Alk.Phos.Isoenzym Leber | % | 7.00 | - | 60.00 | MATERIAL: Serum/Vollblut |
APLAK | Phospholipid AK | - | MATERIAL: Serum/Vollblut | |||
APLAKG | Phospholipid Screen IgG | U/ml | 0.00 | - | 7.00 | MATERIAL: Serum, METHODE: ELISA |
APLAKM | Phospholipid Screen IgM | U/ml | 0.00 | - | 7.00 | MATERIAL: Serum, METHODE: ELISA |
APO10 | APO10 | - | MATERIAL: EDTA, METHODE: | |||
APOA | Apolipoprotein A-1 | mg/dl | - | MATERIAL: Serum, METHODE: turbidimetrisch | ||
APOB | Apolipoprotein B | mg/dl | - | MATERIAL: Serum, METHODE: turbidimetrisch | ||
APOE | APO E Polymorphismus (MGen) | - | MATERIAL: EDTA, METHODE: PCR | |||
APOLIPE | Apolipoprotein E | mg/dl | 2.30 | - | 6.30 | MATERIAL: Serum, METHODE: NEPH |
APOQ | ApoB/ApoA1 Quotient | 0.350 | - | 1.250 | ||
APS | Anti-phospholipid Syndrom | - | Material: Serum+Citrat Methode: diverse | |||
AQUAPOR4AK | Aquaporin-4 Antikörper | Titer | - | MATERIAL: Serum, METHODE: IFT | ||
ARIPIPRA | Aripiprazol | ug/l | 100.0 | - | 350.0 | MATERIAL: Serum, METHODE: LC-MS/MS |
ARTHRITIS | BLOCK ARTHRITIS | - | ||||
AS | Arsen im Serum | ug/l | 0.000 | - | 10.000 | MATERIAL: Serum, METHODE: AAS |
ASCARIS_AK | Ascaris lumbricoides IgG | Units | < | 9.00 | MATERIAL: Serum, METHODE: | |
ASPAGBEURT | Cave Asp.-AG (Galaktomannan): | - | MATERIAL: Serum, METHODE: ELISA | |||
ASPERGA | Aspergillus IgA | U/ml | 0.0 | - | 70.0 | MATERIAL: Serum, METHODE: ELISA |
ASPERGAG | Aspergillus-AG (Galaktomannan) | - | MATERIAL: Serum, METHODE: ELISA | |||
ASPERGG | Aspergillus IgG | U/ml | 0.0 | - | 70.0 | MATERIAL: Serum, METHODE:ELISA |
AST | Antistreptolysin - Titer | U/ml | 0.0 | - | 200.0 | MATERIAL: Serum, METHODE: turbidimetrisch |
ASTA | Antistaphylolysin - Titer | U/ml | 0.00 | - | 2.00 | MATERIAL: Serum, METHODE: Agglutination |
ASTROPCR | Astrovirus (RNA) PCR | - | MATERIAL: Stuhl, METHODE: PCR | |||
ASU | Arsen i.H. | ug/l | 0.000 | - | 15.000 | MATERIAL: Spontanharn, METHODE: AAS |
ASV | Arsen im Vollblut (EDTA) | ug/l | 0.000 | - | 10.000 | MATERIAL: EDTA; METHODE: ICP-MS |
AT3 | Antithrombin III | % | 80.00 | - | 120.00 | MATERIAL: Citrat, METHODE: chromogenes Substrat |
ATOMOXETIN | Atomoxetin | ng/ml | 200.00 | - | 1000.00 | MATERIAL: Serum, METHODE: |
ATP | ATP intracellulär | umol/l | > | 2.500 | MATERIAL: Heparinblut; Methode: CLIA | |
ATRYP | A1-Antitrypsin | mg/dl | 90.00 | - | 200.00 | MATERIAL: Serum, METHODE: turbidimetrisch |
ATRYPGEN | A1-Antitrypsin Genotyp | - | MATERIAL: EDTA, Methode: molekulargenetischer Nachweis | |||
ATRYPPH | A1-Antitrypsin-Phänotyp | - | MATERIAL: Serum | |||
ATRYPST | A1-Antitrypsin i.St. | mg/g St. | 0.000 | - | 0.300 | MATERIAL: Stuhl |
B1ADREZAK | Beta 1 adrenerge Rezeptor AK | U/ml | 0.00 | - | 15.00 | MATERIAL: Serum, Methode: ELISA |
B2ADREZAK | Beta 2 adrenerge Rezeptor AK | U/ml | 0.00 | - | 8.00 | MATERIAL: Serum, Methode: ELISA |
B2GPG | B2-Glykoprotein IgG | U/ml | 0.000 | - | 8.000 | MATERIAL: Serum, METHODE: ELISA |
B2GPM | B2-Glykoprotein IgM | U/ml | 0.000 | - | 8.000 | MATERIAL: Serum, METHODE: ELISA |
B2MG | Beta-2-Mikroglobulin | mg/l | 0.970 | - | 2.640 | MATERIAL: Serum, METHODE: MEIA |
B2MGU | Beta-2-Mikroglobulin i.H. | mg/l | 0.0000 | - | 0.3000 | MATERIAL: Spontanharn, METHODE: MEIA |
B5U | Pantothensäure i.H. | - | MATERIAL: 24h-Sammelharn, METHODE: HPLC | |||
BA | Barium im Serum | ug/l | 0.00 | - | 2.80 | MATERIAL: Serum, METHODE: AAS |
BABDIVG | Babesia divergens IgG-AK | 0.0 | - | 16.0 | MATERIAL: Serum; Methode: IFT | |
BABMICG | Babesia microti IgG-AK | 0.0 | - | 16.0 | MATERIAL: Serum; Methode: IFT | |
BABS | B-Zellen absolut | /mm3 | 90.0 | - | 660.0 | MATERIAL: EDTA, METHODE: Flow cytometrie |
BACLOFEN | Baclofen | ug/l | 80.0 | - | 400.0 | MATERIAL: Serum, METHODE: LC-MS |
BARH | Barbiturate i.H. | ng/ml | 0.0 | - | 200.0 | MATERIAL: Spontanharn, METHODE: EMIT |
BARS | Barbiturate (S) | ug/l | 0.0 | - | 500.0 | MATERIAL: Serum, METHODE: FPIA |
BARTHENSG | Bartonella henselae IgG Ak | - | MATERIAL: Serum, METHODE: IFT | |||
BARTHENSM | Bartonella henselae IgM Ak | - | MATERIAL: Serum, METHODE: IFT | |||
BASO | Basophile | % | 0.00 | - | 2.00 | MATERIAL: EDTA, |
BASOA | Basophile (abs.) | /µl | 0.0 | - | 200.0 | |
BASOP | Basophile | % | - | MATERIAL: Punktat, | ||
BAU | Barium i.H. | ug/l | 0.00 | - | 10.00 | MATERIAL: Spontanharn, METHODE: AAS |
BB | Blutbild mit Diff | - | MATERIAL: EDTA | |||
BBA | Blutbild (abs.) | - | MATERIAL: EDTA | |||
BCAROT | Beta-Carotin | ug/l | 40.00 | - | 322.00 | MATERIAL: Serum, METHODE: HPLC |
BCR_ABL1 | BCR-ABL1 Translokationsnachweis | - | MATERIAL: EDTA 5ml; Methode: PCR | |||
BDEFENST | Beta-Defensin i.St. | ng/ml | 15.0 | - | 60.0 | MATERIAL: Stuhl, METHODE: ELISA |
BDNF | Brain-derived neurot. Factor | ng/ml | 18.30 | - | 31.40 | MATERIAL: Serum, |
BDVAG | Borna-Virus RNA | - | MATERIAL: Liquor | |||
BDVAK | Borna-Disease-Virus Ak IgG | - | MATERIAL: Serum, | |||
BEHENSRE | Behensäure C22:0 | umol/l | 26.50 | - | 110.00 | MATERIAL: Serum Methode: GC-MS |
BENZECGOS | Benzoylecgonin (S) | ug/l | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: FPIA |
BENZH | Benzodiazepine i.H. | ng/ml | 0.0 | - | 200.0 | MATERIAL: Spontanharn, METHODE: EMIT |
BENZS | Benzodiazepine (S) | - | MATERIAL: Serum, METHODE: FPIA | |||
BETA | Beta | % | 7.90 | - | 13.70 | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese |
BETAA | Beta | g/dl | 0.570 | - | 0.990 | |
BETAHBA | ß-Hydroxybuttersäure | umol/l | 30.0 | - | 300.0 | MATERIAL: Serum; METHODE: |
BG | Blutgruppe | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
BGRAD | Gradient im Beta Bereich % | % | - | MATERIAL: Serum, METHODE: Elektrophorese | ||
BGRADA | Gradient im Beta Bereich abs. | g/dl | - | |||
BGRH | Blutgruppe/Rhesus | - | MATERIAL: EDTA, METHODE: Gelzentrifug. | |||
BHCG | Beta-HCG | mIE/ml | 0.00 | - | 5.00 | MATERIAL: Serum, METHODE: MEIA |
BHCGF | Beta-HCG frei | IU/l | - | MATERIAL: Serum, METHODE: TRACE | ||
BILID | Bilirubin direkt | mg/dl | 0.000 | - | 0.500 | MATERIAL: Serum, METHODE: photometrisch |
BILIG | Bilirubin gesamt | mg/dl | 0.000 | - | 1.200 | MATERIAL: Serum, METHODE: photometrisch |
BIOTESTOS | Bioverfügbares Testosteron | - | Material: Serum/ Vollblut | |||
BIPERIDEN | Biperiden | ug/l | 1.00 | - | 6.50 | MATERIAL: Serum, METHODE: LC-MS |
BISPHENOLA | Bisphenol A | ug/l | < | 2.00 | MATERIAL: Serum Methode: GC-MS | |
BJH | Bence Jones Protein i.H. | - | MATERIAL: Spontanharn, METHODE: Immunfixation | |||
BJS | Bence Jones Protein | - | MATERIAL: Serum, METHODE: Immunfixation | |||
BKVPCR | BK-Polyomavirus DNA (PCR) | - | MATERIAL: EDTA-Blut; METHODE: PCR | |||
BLEIH | Blei i.H. | ug/dl | 0.000 | - | 15.000 | MATERIAL: Spontanharn, METHODE: AAS |
BLEIV | Blei im Vollblut (EDTA) | ug/dl | 0.000 | - | 9.000 | MATERIAL: EDTA, METHODE: AAS |
BLUT | Erythrozyten i.H. | /ul | 0.0 | - | 0.1 | MATERIAL: Spontanharn, METHODE: STIX |
BMAEPID | Basalmembran-AK (epidermal) | Titer | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: IFT |
BMAGLOM | Basalmembran-AK (glomerulär) | 0.00 | - | 19.00 | MATERIAL: Serum, METHODE: ELISA | |
BMAGLOM_V | Basalmembran-AK (glomerulär) | U/ml | 0.0 | - | 6.9 | MATERIAL: Serum/Vollblut, METHODE: IFT |
BORBLOTG | Borrelien Blot IgG | - | MATERIAL: Serum, METHODE: Immunoblot | |||
BORBLOTM | Borrelien Blot IgM | - | MATERIAL: Serum, METHODE: Immunoblot | |||
BORELISPOT | Borrelien - EliSpot | - | MATERIAL: CPDA, METHODE: ELISpot Assay | |||
BORG | Borrelien IgG | U/ml | 0.00 | - | 15.00 | MATERIAL: Serum, METHODE: ELISA |
BORG_L | Borrelien IgG i.L. | - | MATERIAL: Liquor, METHODE: ELFA | |||
BORLTT | Borrelien LTT | - | MATERIAL: spez.Abnahme CPDA Heparin, METHODE: | |||
BORM | Borrelien IgM | - | MATERIAL: Serum, METHODE: ELISA | |||
BORM_L | Borrelien IgM i.L. | - | MATERIAL: Liquor, METHODE: ELFA | |||
BORPCR | Borrelia burgd. DNA (PCR) | - | MATERIAL: Liquor/Punktat, METHODE: PCR | |||
BORV | Bor im Vollblut (EDTA) | ug/l | 14.0 | - | 85.0 | MATERIAL: EDTA, METHODE: |
BP180GAK | BP180 (NC16A-4x) IgG AK | Titer | < | 10.0 | MATERIAL: Serum, METHODE: IFT | |
BP230GAK | BP230 IgG AK | Titer | < | 10.0 | MATERIAL: Serum, METHODE: IFT | |
BREL | B-Zellen relativ | % | 7.0 | - | 23.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |
BRIVARAC | Brivaracetam | mg/l | 0.500 | - | 0.900 | MATERIAL: Serum, METHODE: LC-MS |
BROMAZEPAM | Bromazepam | ug/l | 50.00 | - | 200.00 | MATERIAL: Serum, METHODE: LC-MS/MS |
BROMH | Brom im 24h H. | mg/24h | 0.00 | - | 5.00 | MATERIAL: 24h-Sammelharn, METHODE: ICP-MS |
BROMIDS | Bromid im Serum | mg/dl | - | MATERIAL: Serum, Methode: | ||
BROMU | Brom i.H. | ug/ml | - | MATERIAL: Spontanharn, | ||
BRUCG | Brucella IgG-EIA | U/ml | 0.00 | - | 20.00 | MATERIAL: Serum, METHODE: EIA |
BRUCKBR | Brucella KBR | Titer | 0.0 | - | 20.0 | MATERIAL: Serum, Methode: KBR |
BRUCM | Brucella IgM-EIA | U/ml | 0.00 | - | 15.00 | MATERIAL: Serum, METHODE: EIA |
BSR1 | Blutsenkung nach 1h | mm | 0.0 | - | 10.0 | MATERIAL: EDTA, METHODE: Westergreen |
BTRANS | B2-Transferrin (Nasensekret) | ng/ml | 0.00 | - | 5.00 | MATERIAL: Abstrich |
BUPRH | Buprenorphin i.H. | 0.0 | - | 5.0 | MATERIAL: Spontanharn, METHODE: CEDIA | |
BUPRO | Bupropion | ug/l | - | MATERIAL: Serum, METHODE: LC-MS | ||
BUPRO_GES | Bupropion+Hydroxybupropion | ug/l | 850.00 | - | 1500.00 | |
BUPRO_OH | Hydroxybupropion | ug/l | - | MATERIAL: Serum, METHODE: LC-MS | ||
BZ | Blutzucker nüchtern | mg/dl | 60.0 | - | 100.0 | MATERIAL: Fluorid, METHODE: photometrisch |
BZBEL | Blutzuckerbelastung (OGTT) | - | MATERIAL: Fluorid-Blut | |||
BZBELMKP | Oraler Gluc.toleranztest MKP | - | MATERIAL: Fluorid-Blut | |||
BZH | Glukose i.24h H. | mg/24h | - | MATERIAL: 24h-Sammelharn, METHODE: photometrisch | ||
BZP | Prolong.oral.Glukosetoleranz | - | MATERIAL: Fluorid-Blut | |||
BZPPR | Blutzucker postprandial | mg/dl | 60.0 | - | 180.0 | MATERIAL: Fluorid, METHODE: photometrisch |
BZT | Blutzucker Tagesprofil | - | MATERIAL: Fluorid-Blut, METHODE: photometrisch | |||
BZU | Glukose i.H. | mg/dl | 6.0 | - | 20.0 | MATERIAL: Spontanharn, METHODE: photometrisch |
C1 | C1 Penicillin G | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
C155 | C155 Cortison | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
C1INHF | C1-INH funkt. | % | 70.0 | - | 130.0 | MATERIAL: Citrat+Serum |
C1INHQ | C1-INH quant. | g/l | 0.210 | - | 0.380 | MATERIAL: Citrat+Serum |
C2 | C2 Penicillin V | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
C2_comp | Complement C2 | mg/dl | 14.00 | - | 25.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
C209 | C209 Chymopapain | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
C227 | C227 Paracetamol | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
C24_C22_R | C24/C22 Ratio | < | 1.000 | MATERIAL: Serum; METHODE: Calc. | ||
C26_C22_R | C26/C22 Ratio | < | 0.020 | MATERIAL: Serum; METHODE: Calc. | ||
C3_comp | Complement C3 | mg/dl | 90.00 | - | 180.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
C4_comp | Complement C4 | mg/dl | 10.00 | - | 40.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
C5 | C5 Ampicillin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
C6 | C6 Amoxycillin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
C7 | C7 Cefaclor | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
C70 | C70 Insulin Schwein | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
C71 | C71 Insulin Rind | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
C73 | C73 Insulin Human | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
C74 | C74 Gelatine (Schwein) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
CA | Calcium | mmol/l | 2.100 | - | 2.600 | MATERIAL: Serum, METHODE: photometrisch |
CA125 | CA 125 | U/ml | 0.0 | - | 35.0 | MATERIAL: Serum, METHODE: MEIA |
CA15-3 | CA 15-3 | U/ml | 0.0 | - | 35.0 | MATERIAL: Serum, METHODE: MEIA |
CA19-9 | CA 19-9 | U/ml | 0.0 | - | 37.0 | MATERIAL: Serum, METHODE: CMIA |
CA50 | CA 50 | U/ml | < | 25.00 | MATERIAL: Serum Methode: RIA | |
CA72-4 | CA 72-4 | U/ml | 0.00 | - | 6.90 | MATERIAL: Serum, METHODE: EIA |
CAH | Calcium i.24h H. | mmol/24h | 2.500 | - | 7.500 | MATERIAL: 24h-Sammelharn, METHODE: photometrisch |
CAH_I_Ak | Carboanhydrase I Ak | - | MATERIAL: Serum, METHODE: EIA | |||
CAH_II_Ak | Carboanhydrase II Ak | - | MATERIAL: Serum, METHODE: EIA | |||
CAION | Calcium ionisiert (berechnet) | mmol/l | 2.100 | - | 2.600 | MATERIAL: Serum/Vollblut, METHODE:photometrisch |
CAKREAQ | Calcium Kreatinin Ratio | mmol/mmol | 0.000 | - | 0.570 | |
CALC | Calcitonin | pg/ml | 0.000 | - | 9.520 | MATERIAL: Serum, METHODE: EIA |
CALPROTS | Calprotectin | ug/l | 0.00 | - | 3000.00 | MATERIAL: Serum, |
CALPROTST | Calprotectin i.St. | mg/kg | 0.00 | - | 50.00 | MATERIAL: Stuhl, METHODE: ELISA |
CALRETEX9 | Calreticulin Ex9 Mutation | - | MATERIAL: EDTA 5ml; Methode: PCR | |||
CAMP | Campylobakter | - | MATERIAL: Serum/Vollblut, METHODE: KBR | |||
CAMPA | Campylobakter IgA | U/ml | 0.00 | - | 24.00 | MATERIAL: Serum, METHODE: ELISA |
CAMPAG | Campylobakter Erregernachweis | - | MATERIAL: Stuhl, | |||
CAMPG | Campylobakter IgG | U/ml | 0.00 | - | 24.00 | MATERIAL: Serum, METHODE: ELISA |
CAMPKULT | Campylobakter Kultur | - | MATERIAL: Stuhl, METHODE: Kultur | |||
CANCA | ANCA-c (anti-PR-3) | U/ml | 0.00 | - | 20.00 | MATERIAL: Serum, METHODE: CLIA |
CANDA | Candida IgA | IU/ml | 0.000 | - | 80.000 | MATERIAL: Serum, METHODE: ELISA |
CANDAG | Candida Antigen im Serum | - | MATERIAL: Serum, METHODE: Agglutination | |||
CANDG | Candida IgG | IU/ml | 0.000 | - | 100.000 | MATERIAL: Serum, METHODE: ELISA |
CANDM | Candida IgM | IU/ml | 0.000 | - | 80.000 | MATERIAL: Serum, METHODE: ELISA |
CANH | Cannabinoide i.H. | ng/ml | 0.0 | - | 50.0 | MATERIAL: Spontanharn, METHODE: EMIT |
CANS | Cannabinoide (S) | ug/l | 0.00 | - | 10.00 | MATERIAL: Serum, METHODE: FPIA |
CARBA | Carbamazepin | ug/ml | 4.00 | - | 12.00 | MATERIAL: Serum, METHODE: FPIA |
CARIPRAZIN | Cariprazin | ug/l | 10.00 | - | 20.00 | MATERIAL: Serum, METHODE: LC-MS |
CARN | Carnitin (freies) | mg/l | 4.00 | - | 9.80 | MATERIAL: Serum, METHODE: MS |
CASPR2AK | CASPR2-AK (IgG) | Titer | 0.00 | - | 10.00 | MATERIAL: Serum, Methode: IFT |
CAV | Calcium i.Vollblut | mg/dl | 4.600 | - | 6.600 | MATERIAL: EDTA, METHODE: AAS |
CCPAK | Cycl. Citrullin Peptid-AK | U/ml | 0.000 | - | 5.000 | MATERIAL: Serum, Methode: EIA |
CD4_8 | Helfer-Suppressor Ratio | 1.200 | - | 2.500 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie | |
CDH | Cadmium im 24h H. | ug/24h | 0.000 | - | 2.250 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
CDT | CDT-IFCC | % | 0.00 | - | 2.00 | MATERIAL: Serum, METHODE: HPLC |
CDU | Cadmium i.H. | ug/l | 0.000 | - | 0.800 | MATERIAL: Spontanharn, METHODE: AAS |
CDUKR | Cadmium /g Krea i.H. | ug/g Krea | 0.000 | - | 2.500 | MATERIAL: Spontanharn, METHODE: |
CDV | Cadmium im Vollblut (EDTA) | ug/dl | 0.000 | - | 0.100 | MATERIAL: EDTA, METHODE: AAS |
CEA | CEA | ng/ml | 0.00 | - | 3.00 | MATERIAL: Serum, METHODE: CMIA |
CENOBAMAT | Cenobamat | mg/l | 5.00 | - | 35.00 | MATERIAL: 2xSerum; METHODE: LC-MS |
CENPB | Centromer AK (quantitativ) | EliAU/ml | 0.00 | - | 6.90 | MATERIAL: Serum, METHODE: |
CEROTINSRE | Cerotinsäure C26:0 | umol/l | 0.20 | - | 1.60 | MATERIAL: Serum Methode: GC-MS |
CGA | Chromogranin A | ug/l | 0.00 | - | 100.00 | MATERIAL: Serum, Methode: LIA (TRIF) |
CH50 | CH-50 | U/ml | 32.0 | - | 58.0 | MATERIAL: Serum, METHODE: turbidimetrisch |
CHE | Cholinesterase | kU/l | 2.90 | - | 12.90 | MATERIAL: Serum, METHODE: photometrisch |
CHL_L1-L3 | Chl.trach. DNA L1-L3 | - | MATERIAL: Abstrich, METHODE: PCR | |||
CHL_L1-L3H | Chl.trach. DNA L1-L3 i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
CHL_ompA | Chl.trach. DNA ompA Gen | - | MATERIAL: Abstrich, METHODE: PCR | |||
CHL_ompAH | Chl.trach. DNA ompA Gen i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
CHLOROQUIN | Hydrochloroquin | ug/l | - | MATERIAL: Serum, METHODE: LC-MS | ||
CHLORPROT | Chlorprothixen | ng/ml | 20.00 | - | 300.00 | MATERIAL: Serum, METHODE: LC-MS |
CHLPNEUA | Chlamydia pneumoniae IgA | U/ml | 0.00 | - | 25.00 | MATERIAL: Serum, METHODE: Immunfluoreszenz |
CHLPNEUG | Chlamydia pneumoniae IgG | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
CHLPNEUM | Chlamydia pneumoniae IgM | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
CHLPSIT | Chlamydia psittaci (KBR) | 0.0 | - | 19.9 | MATERIAL: Serum, METHODE: KBR | |
CHLPSITA | Chlamydia psittaci IgA | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: IFT | |
CHLPSITG | Chlamydia psittaci IgG | 0.0 | - | 100.0 | MATERIAL: Serum, METHODE: IFT | |
CHLPSITM | Chlamydia psittaci IgM | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: IFT | |
CHLTRACHA | Chlamydia trachomatis IgA | - | MATERIAL: Serum, METHODE: ELISA | |||
CHLTRACHG | Chlamydia trachomatis IgG | - | MATERIAL: Serum, METHODE: ELISA | |||
CHLTRPCR | Chl.trachomatis DNA (PCR) | - | MATERIAL: Serum/Sputum/Punktat, METHODE: PCR | |||
CHLTRPCRAB | Chlamydia trach.(PCR) i.Abstr. | - | MATERIAL: Abstrich, METHODE: PCR | |||
CHLTRPCRU | Chl.trach.PCR i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
CHOL | Cholesterin | mg/dl | < | 200.0 | MATERIAL: Serum, METHODE: photometrisch | |
CHOLRAT | Cholesterin-Ratio | - | ||||
CIC1Q | CIC-C1q-IgG | ug/ml | 0.0 | - | 45.0 | MATERIAL: Serum/Vollblut, METHODE: ID |
CIC3D | CIC-C3d-IgG | ug/ml | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
CITALO | Citalopram | ng/ml | 50.00 | - | 110.00 | MATERIAL: Serum, METHODE: HPLC |
CITRATH | Citrat im 24h H. | mg/24h | 300.00 | - | 860.00 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: GC-MS |
CITRULLINU | Citrullin /mol Krea i.H. | mmol/mol Kreat | 0.00 | - | 4.00 | MATERIAL: 2.Morgenharn, Methode: LC-MS |
CK | CK | U/l | 29.00 | - | 200.00 | MATERIAL: Serum, METHODE: photometrisch |
CKBB-E | CK-BB | % | - | MATERIAL: Serum, METHODE: ELPHOR | ||
CKELPHOR | CK-Isoenzym-Elektrophorese | - | MATERIAL: Serum/Vollblut | |||
CKMAKRO1 | Makro-CK Typ 1 | - | MATERIAL: Serum, | |||
CKMAKRO2 | Makro-CK Typ 2 | - | MATERIAL: Serum, | |||
CKMB | CK-MB | U/l | 0.0 | - | 24.0 | MATERIAL: Serum, METHODE: photometrisch |
CKMB% | CK-MB relativ | % | - | MATERIAL: Serum/Vollblut, METHODE: GC/MS | ||
CKMB-E | CK-MB | % | 0.00 | - | 3.00 | MATERIAL: Serum, METHODE: ELPHOR |
CKMM-E | CK-MM | % | 97.00 | - | 100.00 | MATERIAL: Serum, METHODE: ELPHOR |
CL | Chlorid | mmol/l | 95.0 | - | 110.0 | MATERIAL: Serum, METHODE: ISE |
CLEAR | Kreatinin - Clearance | ml/min | 95.000 | - | 160.000 | MATERIAL: Serum/Vollblut+24h Sammelharn |
CLH | Chlorid i.24h H. | mmol/24h | 2.0 | - | 250.0 | MATERIAL: 24h-Sammelharn, METHODE: ISE |
CLINDA | Clindamycin | mg/l | - | MATERIAL: Serum, METHODE: | ||
CLNORQ_STA | Clozapin-Norclozapin-Quotient | 1.000 | - | 2.500 | ||
CLOBA | Clobazam | ug/l | 30.00 | - | 300.00 | MATERIAL: Serum, METHODE: LC-MS/MS |
CLOMI_GES | Clomipramin + Norclomipramin | ng/ml | 230.00 | - | 450.00 | |
CLONA | Clonazepam | ug/l | 10.00 | - | 80.00 | MATERIAL: Serum, METHODE: LC-MS |
CLOS | Clos.diff.Toxinnachweis i.St. | - | MATERIAL: Stuhl, | |||
CLOZ | Clozapin | ng/ml | 350.00 | - | 600.00 | MATERIAL: Serum, METHODE: LC-MS |
CLOZDESME | Clozapin (Desmethyl-) | ng/ml | - | MATERIAL: Serum, METHODE: LC-MS | ||
CLOZNOXID | Clozapin-N-Oxid | ng/ml | 15.00 | - | 140.00 | MATERIAL: Serum, METHODE: LC-MS |
CMV | CMV IgG | - | MATERIAL: Serum, METHODE: ELFA | |||
CMVAVID | Cytomegalie IgG Avidität | - | MATERIAL: Serum, | |||
CMVKBR | Cytomegalie KBR | Titer | 0.0 | - | 40.0 | MATERIAL: Serum, METHODE: KBR |
CMVM | CMV IgM | - | MATERIAL: Serum, METHODE: ELFA | |||
CMVPCR | CMV-Virus DNA (PCR) | - | MATERIAL: EDTA, METHODE: PCR | |||
CO | Cobalt im Serum | ug/l | 0.00 | - | 0.60 | MATERIAL: Serum/Vollblut, METHODE: ICP-MS |
COCH | Cocainmetabolite i.H. | ng/ml | 0.0 | - | 300.0 | MATERIAL: Spontanharn, METHODE: EMIT |
COCS | Cocainmetabolite (S) | ug/l | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: FPIA |
COERU | Coeruloplasmin | mg/dl | 15.00 | - | 45.00 | MATERIAL: Serum, METHODE: Immunologischer Trübungstest |
COFF | Coffein (S) | ug/ml | 5.000 | - | 20.000 | MATERIAL: Serum, METHODE: HPLC |
COH | Cobalt im 24h H. | ug/24h | 0.00 | - | 1.50 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
COMP | Cartilage Olig.Matrix Protein | U/l | 0.0 | - | 15.0 | MATERIAL: Serum, METHODE: EIA |
COPA | CT-proAVP (Copeptin) | pmol/l | - | MATERIAL: Serum/Vollblut | ||
CORT | Cortisol | ug/dl | 4.80 | - | 19.50 | MATERIAL: Serum, METHODE: LIA |
CORT_SP | Cortisol im Speichel | ug/dl | 0.0000 | - | 0.8740 | MATERIAL: Speichel, METHODE: ECLIA |
CORTH | Cortisol i.24h H. | ug/24h | 11.50 | - | 102.00 | MATERIAL: 24h-Sammelharn, METHODE: LIA |
COTS | Cotinin | µg/l | 0.0 | - | 10.0 | MATERIAL: Serum, |
COTU | Cotinin i.H. | ng/ml | 0.0 | - | 20.0 | MATERIAL: Spontanharn, |
COU | Cobalt i.H. | ug/l | 0.00 | - | 1.00 | MATERIAL: Spontanharn, METHODE: AAS |
COUKR | Cobalt /g Krea i.H. | ug/g Krea | - | MATERIAL: Spontanharn, METHODE: AAS/Clia | ||
COVAG | SARS-CoV-2 Antigen (Roche) | - | MATERIAL: Abstrich, METHODE: Immunchromatographischer Test | |||
COVGABNEUT | Neutralis. AK COVID19 Roche | BAU/ml | 0.00 | - | 14.90 | MATERIAL: Serum, METHODE: CMIA |
COVGABWHO | entspricht dem WHO-Standard | BAU/ml | - | MATERIAL: Serum/Vollblut | ||
COVMAB | COVID19 IgM-Ak (Diasorin) | - | MATERIAL: Serum, METHODE: CMIA | |||
COVNUKAB | COVID19 N-Kapsid AK (Roche) | - | MATERIAL: Serum, METHODE: immunologisch | |||
COVPCR | SARS-CoV-2 (RT-PCR) | - | MATERIAL: Abstrich, METHODE: RT-PCR | |||
CPEP | C-Peptid | ng/ml | 1.10 | - | 4.40 | MATERIAL: Serum, METHODE: LIA |
CPSA | PSA komplexiert | ng/ml | 0.000 | - | 3.700 | MATERIAL: Serum, METHODE: CLIA |
CR | Chrom im Serum | ug/l | 0.000 | - | 0.500 | MATERIAL: Serum, METHODE: AAS |
CRH | Chrom i.24h H. | ug/24h | 0.00 | - | 0.90 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
CRP | CRP | mg/dl | 0.000 | - | 0.500 | MATERIAL: Serum, METHODE: turbidimetrisch |
CRPP | CRP im Punktat | mg/dl | - | MATERIAL: Punktat, METHODE: turbidimetrisch | ||
CRU | Chrom i.H. | ug/l | 0.000 | - | 0.600 | MATERIAL: Spontanharn, METHODE: AAS |
CRV | Chrom im Vollblut (EDTA) | ug/l | 0.500 | - | 4.000 | MATERIAL: EDTA, METHODE: AAS |
CRYPTOST | Cryptosporidien i.St. | - | MATERIAL: Stuhl, | |||
CTX | CTX (ß-Crosslaps) | ng/l | 118.0 | - | 1060.0 | MATERIAL: Serum, Methode: ECLID |
CTX_V | CTX (ß-Crosslaps) | ng/ml | 0.000 | - | 1.000 | MATERIAL: Serum, Methode: ECLID |
CU | Kupfer | umol/l | 11.00 | - | 24.40 | MATERIAL: Serum, METHODE: photometrisch |
CUH | Kupfer i.24h H. | ug/24h | 10.00 | - | 60.00 | MATERIAL: 24h-Sammelharn, METHODE: photometrisch |
CUU | Kupfer i.H. | ug/l | - | MATERIAL: Spontanharn, METHODE: photometrisch | ||
CUV | Kupfer im Vollblut (EDTA) | umol/l | 10.70 | - | 20.70 | MATERIAL: EDTA, METHODE: ICP-A |
CYCLO | Cyclosporin A monokl. | ug/l | - | MATERIAL: EDTA, METHODE: FPIA | ||
CYFRA | CYFRA 21-1 | ng/ml | 0.000 | - | 2.370 | MATERIAL: Serum, METHODE: TRACE |
CYPP450 | CYP P450 | - | MATERIAL: EDTA (5ml), Methode: Gentest | |||
CYSC | Cystatin C | mg/l | 0.590 | - | 1.380 | MATERIAL: Serum, Methode: Immunturbidimetrie |
CYSTATU | Cystathionin i.H. | ug/l | 80.00 | - | 11000.00 | MATERIAL: 2.Morgenharn, Methode: LC-MS |
CYTABS | Cytotoxische Zellen absolut | /mm3 | 0.0 | - | 70.0 | MATERIAL: EDTA, METHODE: Flow cytometrie |
CYTREL | Cytotoxische Zellen relativ | % | 0.0 | - | 3.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |
D1 | D1 Hausstaubmilbe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
D2 | D2 Mehlmilbe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
D202 | D202 rDer p 1 Milbe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
D203 | D203 rDer p 2 Milbe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
D205 | D205 rDer p 10 Milbe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
D209 | D209 rDer p 23 Milbe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
D3 | D3 Staubmilbe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
D70 | D70 Acarus siro | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
D71 | D71 Lepidoglyphus destr. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
D72 | D72 Tyrophagus putresc. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
D74 | D74 Euroglyphus maynei | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
DAO | Diaminooxidase | U/ml | > | 10.00 | MATERIAL: Serum, METHODE: ELISA | |
DAS | Delta-Aminolävulinsäure i.H. | mg/l | 0.10 | - | 4.50 | MATERIAL: Spontanharn, METHODE: Chromatographie |
DCT | Coombstest direkt | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
DD | D-Dimer | ug/l | 0.00 | - | 500.00 | MATERIAL: Citrat, METHODE: ELFA |
DDPMUKR | 4,4-Diaminodiph.CH4 /g Kr i.H. | ug/g Krea | < | 10.00 | MATERIAL: Spontanharn, METHODE: | |
DDT | Dichlordiphenyltrichlorethan | ug/l | < | 0.150 | MATERIAL: Spezialröhrchen, METHODE: GC-MS | |
DENGUEAG | Dengue-Virus Antigen | - | MATERIAL: Serum/Vollblut, METHODE: ICT Chromatographie | |||
DENGUEM | Dengue-Virus IgM | - | MATERIAL: Serum/Vollblut, METHODE: ICT Chromatographie | |||
DESAMIO | Desethylamiodaron (akt.Metab.) | ug/l | 500.0 | - | 3000.0 | MATERIAL: Serum, METHODE: HPLC |
DESMETFLUO | Desmethylfluoxetin | ug/l | - | MATERIAL: Serum, Methode: LC-MS/MS | ||
DESVENLA | O-Desmethyl-Venlafaxin | ng/ml | - | MATERIAL: Serum, METHODE: LC-MS | ||
DFS70 | DFS70 | - | MATERIAL: Serum, METHODE: Immunoblot | |||
DGP_AK_A | Gliadin IgA-AK gg.deamid.Peptid | U/ml | 0.00 | - | 10.00 | MATERIAL: Serum, METHODE: ELISA |
DGP_AK_G | Gliadin IgG-AK gg.deamid.Peptid | U/ml | 0.00 | - | 10.00 | MATERIAL: Serum, METHODE: ELISA |
DHCODEINU | Dihydrocodein i.H. | ug/l | 0.00 | - | 0.50 | MATERIAL: Spontanharn, Methode: LC-MS |
DHEA_SP | DHEA im Speichel | pg/ml | - | MATERIAL: Speichel, METHODE: | ||
DHEAS | DHEA-S | ug/dl | 8.60 | - | 591.90 | MATERIAL: Serum, METHODE: LIA |
DHEAS60 | DHEA-S nach 60 min | ug/ml | - | MATERIAL: Serum, METHODE: LIA | ||
DHT | Dihydro-Testosteron | ug/l | - | MATERIAL: Serum; Methode: RIA | ||
DIAMINMDA | 4,4-Diaminodiphenylmethan i.H. | ug/l | - | MATERIAL: Spontanharn, METHODE: GC | ||
DIAZEPAM | Diazepam + Nordiazepam | ug/l | 200.0 | - | 2500.0 | MATERIAL: Serum, METHODE: LC-MS |
DIBUCAIN | Dibucainzahl | % | 71.0 | - | 100.0 | MATERIAL: Serum, METHODE: photometrisch |
DICLO | Diclofenac | ug/l | 100.0 | - | 2500.0 | MATERIAL: Serum, METHODE: LC-MS |
DIFF | Differential-Blutbild | - | MATERIAL: EDTA | |||
DIFFA | Differential-Blutbild (abs.) | - | MATERIAL: EDTA | |||
DIFFP | Leukozytendiff. im Punktat | - | MATERIAL: Punktat | |||
DIGI | Digitoxin | ng/ml | 10.00 | - | 25.00 | MATERIAL: Serum, METHODE: FPIA |
DIGO | Digoxin | ng/ml | 0.800 | - | 2.000 | MATERIAL: Serum, METHODE: FPIA |
DIPHTQUANT | Diphterie-AK Impftiter | IU/ml | - | MATERIAL: Serum, | ||
DONEPEZIL | Donepezil | ug/l | - | Material: Serum; Methode: LC-MS | ||
DOPH | Dopamin i.24h H. | ug/24h | 62.00 | - | 446.00 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
DOPS | Dopamin (P) | pg/ml | 0.0 | - | 30.0 | MATERIAL: EDTA Plasma, METHODE: HPLC |
DOXEP_GES | Doxepin + Nordoxepin | ug/l | 50.00 | - | 150.00 | |
DPD | Desoxypyridinolin /g Krea i.H. | ug/g Krea | 15.000 | - | 80.000 | MATERIAL: Spontanharn, METHODE: LIA |
DPPXAK | DPPX-AK (IgG) | Titer | - | MATERIAL: Serum, Methode: IFT | ||
DRVVT | Russel-Viper-Venom-Zeit (DRVVT) | Ratio | 0.000 | - | 1.200 | MATERIAL: Citrat, |
DSG1AK | Desmoglein 1-AK (IFT) | Titer | < | 10.0 | MATERIAL: Serum, METHODE: IFT | |
DSG3AK | Desmoglein 3-AK (IFT) | Titer | < | 10.0 | MATERIAL: Serum, METHODE: IFT | |
DU_F_klein | Durchuntersuchung Frau klein | - | ||||
DU_F_ksub | Durchuntersuchung Frau kl.sub | - | ||||
DU_M_klein | Durchuntersuchung Mann klein | - | ||||
DU_M_ksub | Durchuntersuchung Mann kl.sub | - | ||||
DULOX | Duloxetin | ng/ml | 30.00 | - | 120.00 | MATERIAL: Serum, METHODE: LC-MS |
DVFORMEL | Rhesus Dvariant Formel | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
E1 | E1 Katzenepithel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E203 | E203 Nerz | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E204 | E204 nBos d6 Rinderserumalbumin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E213 | E213 Papageienfedern | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E215 | E215 Taubenfedern | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E3 | E3 Pferdeepithel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E3G | P-AK: Pferdeschuppen IgG-AK | mg/l | 0.000 | - | 15.000 | MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK |
E4 | E4 Rinderepithel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E5 | E5 Hundeschuppen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E6 | E6 Meerschweinchen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E7 | E7 Taubenkot | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E70 | E70 Gänsefedern | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E70G | P-AK: Gänsefedern IgG-AK | mg/l | 0.000 | - | 10.000 | MATERIAL: Serum, METHODE: CLIA; präz.IgG-AK |
E71 | E71 Mäuseepithel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E73 | E73 Rattenepithel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E77 | E77 Wellensittichkot | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E77GP | P-AK: Wellensittichkot IgG-AK | mg/l | < | 9.000 | MATERIAL: Serum, METHODE: FEIA | |
E78 | E78 Wellensittich | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E78G | P-AK: Wellensittichfeder IgG-AK | mg/l | < | 8.000 | MATERIAL: Serum, METHODE: FEIA | |
E80 | E80 Ziegenepithel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E81 | E81 Schafepithel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E82 | E82 Kaninchenepithel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E83 | E83 Schweineepithel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E84 | E84 Goldhamster | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E85 | E85 Hühnerfedern | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E85G | P-AK: Hühnerfedern IgG-AK | mg/l | 0.000 | - | 14.000 | MATERIAL: Serum, METHODE: CLIA; präz.IgG-AK |
E86 | E86 Entenfedern | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E86G | P-AK: Entenfedern IgG-AK | mg/l | 0.000 | - | 10.000 | MATERIAL: Serum, METHODE: CLIA; präz.IgG-AK |
E87 | E87 Ratten-Epith./Protein | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E88 | E88 Maus-Epith./Protein | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E90 | E90 Kanarienvogel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
E94 | E94 rFel d1 Katze | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
EA | EA (early antigen-EBV-AK) | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
EBNA | EBNA (nukleus-antigen-EBV-AK) | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
EBVAVID | EBV IgG Avidität | - | MATERIAL: Serum/Vollblut | |||
EBVG | EBV IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
EBVM | EBV IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
EBVPCR | EBV-Virus DNA (PCR) | - | MATERIAL: EDTA, METHODE: PCR | |||
ECGRAN | Echinococcus granulosus (ELISA) | - | MATERIAL: Serum/Vollblut | |||
ECGRANMULT | Echinococcus gran. und mult. | - | MATERIAL: Serum/Vollblut METHODE: ELISA | |||
ECMULT | Echinococcus multiloc. (ELISA) | - | MATERIAL: Serum/Vollblut | |||
ECP | Eosinoph.Kationic Protein | ug/l | < | 13.30 | MATERIAL: Serum, METHODE: LIA, spez. Präanalytik!! | |
ECSPP | Echinococcus spp. (WB) | - | MATERIAL: Serum/Vollblut; METHODE: Westernblot | |||
ECSTASYH | Ecstasy i.H. | ng/ml | 0.0 | - | 500.0 | MATERIAL: Spontanharn, METHODE: CEDIA |
EDDPH | Methadon-Metabolit (EDDP) i.H. | ng/ml | 0.0 | - | 100.0 | MATERIAL: Spontanharn, METHODE: CEDIA |
eGFR | Glom. Filtrationsrate (CAPA) | ml/min/1,73m2 | - | |||
EHEC | Enterohämorrhag.E.coli Toxin | - | MATERIAL: Stuhl, METHODE: ELISA | |||
ELASTS | Elastase im Serum | ng/ml | < | 3.50 | MATERIAL: Serum/Vollblut | |
ELASTST | Elastase i.St. | ug/g | 200.00 | - | 650.00 | MATERIAL: Stuhl |
ELPHH | Elektrophorese i.H. | - | MATERIAL: Spontanharn, METHODE: Elektrophorese | |||
ELPHOR | Elektrophorese im Serum | - | MATERIAL: Serum/Vollblut | |||
EMA | Endomysium Antikörper IgA | Titer | 0.0 | - | 10.0 | MATERIAL: Serum/Vollblut |
ENA | ENA (ANA Subsets) | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
ENDOA | Endothel-AK (Gefäß) | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
ENT | Entamoeba histolytica | - | MATERIAL: Serum/Vollblut, METHODE: KBR | |||
ENTERO | Entero-Viren (Cox,Echo) | - | ||||
ENTEROG | Entero-Viren IgG (Cox,Echo) | Ratio | 0.00 | - | 0.80 | MATERIAL: Serum, METHODE: ELISA |
ENTEROM | Entero-Viren IgM (Cox,Echo) | Ratio | 0.00 | - | 0.80 | MATERIAL: Serum, METHODE: ELISA |
ENTG | Entamoeba hist. IgG | U/ml | < | 8.50 | MATERIAL: Serum/Vollblut, METHODE: ELISA | |
ENTIHA | Amoeben IHA | - | MATERIAL: Serum/Vollblut, METHODE: indir.Hämagglut. | |||
ENTM | Entamoeba hist. IgM | 0.0 | - | 12.0 | MATERIAL: Serum/Vollblut, METHODE: ELISA | |
EO | Eosinophile | % | 0.00 | - | 7.00 | MATERIAL: EDTA, |
EOA | Eosinophile (abs.) | /µl | 0.0 | - | 450.0 | |
EOP | Eosinophile | % | - | MATERIAL: Punktat | ||
EPP | Freie Erythrozytenporphyrine | ug/dl | 0.0 | - | 120.0 | MATERIAL: EDTA, METHODE: fluorimetrisch |
ERY | Erythrozyten | T/l | 4.000 | - | 5.500 | MATERIAL: EDTA, |
ERYP | Erythrozyten im Punktat | Zahl/ul | - | MATERIAL: Punktat, METHODE: mikroskopisch | ||
ERYPO | Erythropoietin | U/l | 4.30 | - | 29.00 | MATERIAL: Serum/Vollblut, METHODE: LIA |
ESCITALO | Escitalopram | ng/ml | 15.00 | - | 80.00 | MATERIAL: Serum/Vollblut METHODE: HPLC |
ETGH | Ethylglucuronid i.H. | ug/l | 0.0 | - | 100.0 | MATERIAL: Spontanharn, METHODE: EIA |
ETHO | Ethosuximid | ug/ml | 40.00 | - | 100.00 | MATERIAL: Serum/Vollblut, METHODE: FPIA |
ETSH | Ethylsulfat i.H. | ug/l | 0.0 | - | 100.0 | MATERIAL: Spontanharn, METHODE: EIA |
EVERO | Everolimus | ug/l | - | MATERIAL: EDTA, METHODE: LC/MS | ||
EX1 | EX1 Hoftiere | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
EX2 | EX2 Haustiere | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
EX71 | EX71 Federmix 1 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
EX72 | EX72 Federmix Käfigvögel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
EX73 | EX73 Federmix 2 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
EXANTHEM | BLOCK EXANTHEM | - | ||||
F1 | F1 Hühnereiweiß | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F10 | F10 Sesamsaat | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F11 | F11 Buchweizen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F12 | F12 Erbse | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F124 | F124 Dinkel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F13 | F13 Erdnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F14 | F14 Sojamehl | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F15 | F15 Weiße Bohne | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F151 | F151 Zucchini | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F17 | F17 Haselnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F18 | F18 Paranuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F2 | F2 Kuhmilch | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F20 | F20 Mandel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F201 | F201 Pekannuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F202 | F202 Cashewnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F203 | F203 Pistazie | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F204 | F204 Forelle | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F205 | F205 Hering | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F208 | F208 Zitrone | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F209 | F209 Grapefruit | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F210 | F210 Ananas | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F211 | F211 Brombeere | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F212 | F212 Champignon | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F213 | F213 Kaninchenfleisch | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F214 | F214 Spinat | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F216 | F216 Kohl | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F217 | F217 Kohlsprossen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F218 | F218 Paprika | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F220 | F220 Zimt | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F221 | F221 Kaffee | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F224 | F224 Mohnsamen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F226 | F226 Kürbissamen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F23 | F23 Krabbe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F232 | F232 nGal d 2 Ovalbumin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F233 | F233 nGal d 1 Ovomucoid | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F234 | F234 Vanille | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F235 | F235 Linsen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F237 | F237 Aprikose | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F24 | F24 Garnele | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F242 | F242 Kirsche | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F244 | F244 Gurke | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F247 | F247 Honig | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F25 | F25 Tomate | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F253 | F253 Pinienkerne | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F255 | F255 Pflaume | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F256 | F256 Walnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F259 | F259 Weintraube | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F26 | F26 Schweinefleisch | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F260 | F260 Broccoli | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F261 | F261 Spargel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F262 | F262 Aubergine | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F265 | F265 Kümmel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F268 | F268 Nelke | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F269 | F269 Basilikum | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F27 | F27 Rindfleisch | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F270 | F270 Ingwer | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F271 | F271 Anis | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F273 | F273 Thymian | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F276 | F276 Fenchelknolle | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F277 | F277 Dill | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F279 | F279 Chilipfeffer | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F280 | F280 Schwarzer Pfeffer | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F281 | F281 Curry | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F282 | F282 Muskatnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F284 | F284 Truthahn | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F288 | F288 Blaubeere | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F289 | F289 Dattel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F290 | F290 Austern | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F291 | F291 Karfiol | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F299 | F299 Marone | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F3 | F3 Kabeljau | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F302 | F302 Mandarine/Clementine | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F31 | F31 Karotte | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F317 | F317 Koriander | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F319 | F319 Rote Beete | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F322 | F322 Johannisbeere | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F323 | F323 nGal d 3 Ei-Conalbumin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F325 | F325 Schafsmilch | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F328 | F328 Feige | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F33 | F33 Orange | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F333 | F333 Leinsamen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F342 | F342 Olive, schwarz | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F343 | F343 Himbeere | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F345 | F345 Macadamianuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F35 | F35 Kartoffel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F351 | F351 SchrimpsTropo. rPen a1 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F352 | F352 rAra h 8 Erdnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F353 | F353 rGly m 4 Soja | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F36 | F36 Kokosnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F37 | F37 Miesmuschel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F4 | F4 Weizenmehl | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F40 | F40 Thunfisch | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F409 | F409 Ziegenmilch | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F41 | F41 Lachs | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F416 | F416 Om-5 Gliadin Tri a 19 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F419 | F419 rPru p 1 Pfirsich | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F420 | F420 rPru p 3 Pfirsich | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F421 | F421 rPru p 4 Pfirsich | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F422 | F422 rAra h 1 Erdnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F423 | F423 rAra h 2 Erdnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F424 | F424 rAra h 3 Erdnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F425 | F425 rCor a 8 Haselnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F427 | F427 rAra h 9 Erdnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F428 | F428 rCor a 1 Haselnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F431 | F431 nGly m 5 Soja | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F432 | F432 nGly m 6 Soja | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F433 | F433 Tri a 14 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F435 | F435 rMal d 3 Apfel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F439 | F439 rCor a 14 Haselnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F44 | F44 Erdbeere | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F440 | F440 rCor a 9 Haselnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F441 | F441 Walnuss rJug r1 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F442 | F442 Walnuss rJug r3 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F443 | F443 Cashewnuss Ana o3 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F447 | F447 rAra h 6 Erdnuss | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F45 | F45 Bäckerhefe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F47 | F47 Knoblauch | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F48 | F48 Zwiebel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F49 | F49 Apfel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F5 | F5 Roggenmehl | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F517 | F517 Brauereihefe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F54 | F54 Süßkartoffel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F55 | F55 Rispenhirse | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F58 | F58 Tintenfisch (Pazifik) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F59 | F59 Oktopus | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F6 | F6 Gerstenmehl | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F7 | F7 Hafermehl | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F75 | F75 Eigelb | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F76 | F76 Alpha-Lactalbumin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F77 | F77 Beta-Lactglobulin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F78 | F78 Kasein | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F79 | F79 Gluten | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F8 | F8 Maismehl | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F80 | F80 Hummer | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F81 | F81 Cheddarkäse | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F82 | F82 Schimmelkäse | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F83 | F83 Hühnerfleisch | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F84 | F84 Kiwi | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F85 | F85 Sellerie | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F86 | F86 Petersilie | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F87 | F87 Melone | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F88 | F88 Lammfleisch | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F89 | F89 Senf | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F9 | F9 Reis | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F90 | F90 Malz | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F91 | F91 Mango | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F92 | F92 Banane | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F93 | F93 Kakao | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F94 | F94 Birne | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F95 | F95 Pfirsich | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F96 | F96 Avocado | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
F98 | F98 Gliadin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FAI | freier Androgenindex | - | ||||
FAKII | Faktor II | % | 70.00 | - | 150.00 | MATERIAL: Citrat, METHODE: koagulometrisch |
FAKIX | Faktor IX | % | 70.00 | - | 120.00 | MATERIAL: Citrat, METHODE: koagulometrisch |
FAKTINAK | F-Aktin Ak | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
FAKV | Faktor V | % | 62.00 | - | 139.00 | MATERIAL: Citrat, METHODE: koagulometrisch |
FAKVII | Faktor VII | % | 70.0 | - | 150.0 | MATERIAL: Citrat, METHODE: koagulometrisch |
FAKVIII | Faktor VIII | % | 50.0 | - | 150.0 | MATERIAL: Citrat, METHODE: koagulometrisch |
FAKX | Faktor X | % | 70.0 | - | 150.0 | MATERIAL: Citrat, METHODE: koagulometrisch |
FAKXa | Faktor Xa (LMW-Heparin) | U/ml | - | MATERIAL: Citrat, METHODE: koagulometrisch | ||
FAKXI | Faktor XI | % | 70.0 | - | 150.0 | MATERIAL: Citrat, METHODE: koagulometrisch |
FAKXII | Faktor XII | % | 70.0 | - | 150.0 | MATERIAL: Citrat, METHODE: koagulometrisch |
FAKXIII | Faktor XIII-Aktivität | % | 70.0 | - | 150.0 | MATERIAL: Citrat, METHODE: koagulometrisch |
FE | Eisen | ug/dl | 50.0 | - | 175.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
FENTAH | Fentanyl i.H. | ug/l | 0.00 | - | 1.00 | MATERIAL: Spontanharn, METHODE: LC-MS/MS |
FERRI | Ferritin | ng/ml | 10.00 | - | 400.00 | MATERIAL: Serum/Vollblut, METHODE: turbidimetrisch |
FES | Eisensättigung | % | 20.00 | - | 50.00 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
FHB | Freies Hämoglobin | mg/dl | 0.00 | - | 12.00 | MATERIAL: Li-Heparinblut, METHODE: photometrisch |
FIBRI | Fibrinogen | mg/dl | 180.0 | - | 350.0 | MATERIAL: Citrat, METHODE: nach Clauss |
FLECAINID | Flecainid | mg/l | 0.450 | - | 0.900 | MATERIAL: Serum, Methode: LC-MS |
FLUORID | Fluorid im Serum | ug/l | 0.000 | - | 30.000 | MATERIAL: Serum/Vollblut, METHODE: AAS |
FLUORIDH | Fluorid /g Krea i.H. | mg/g Krea | 0.00 | - | 7.00 | MATERIAL: Spontanharn, METHODE: photomet. |
FLUOX_GES | Fluoxetin + Desmethylfluoxetin | ug/l | 120.00 | - | 500.00 | |
FLUOXETIN | Fluoxetin | ug/l | - | MATERIAL: Serum/Vollblut, METHODE: LC-MS | ||
FLUPENT | Flupentixol | µg/l | 0.50 | - | 5.00 | MATERIAL: Serum/Vollblut METHODE: LC-MS |
FLUPHENAZ | Fluphenazin | ng/ml | - | MATERIAL: Serum/Vollblut METHODE: LC-MS | ||
FLUVOXAMIN | Fluvoxamin | ng/ml | 60.00 | - | 230.00 | MATERIAL: Serum/Vollblut METHODE: LC-MS |
FODRINA | Fodrin alpha IgA-AK | AK-Ratio | 0.000 | - | 10.000 | MATERIAL: Serum, METHODE: |
FODRING | Fodrin alpha IgG-AK | AK-Ratio | 0.000 | - | 10.000 | MATERIAL: Serum, METHODE: |
FOL | Folsäure | ng/ml | 3.90 | - | 26.80 | MATERIAL: Serum/Vollblut, METHODE: CMIA |
FOLERY | Folsäure im Erythrozyten | ng/ml | 400.0 | - | 4000.0 | MATERIAL: EDTA, METHODE: |
FR | Francisellen (KBR) | - | MATERIAL: Serum/Vollblut, METHODE: Agglutination | |||
FRANCG | Francisella tularensis IgG | U/ml | < | 10.00 | MATERIAL: Serum/Vollblut, METHODE: ELISA | |
FRANCM | Francisella tularensis IgM | U/ml | < | 10.00 | MATERIAL: Serum/Vollblut, METHODE: ELISA | |
FRUCTGEN | Hered.Fruktoseintoleranz(HFI) | - | MATERIAL: EDTA; Methode: Gentest | |||
FRUCTO | Fructosamin | umol/l | 205.0 | - | 285.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
FSH | FSH (Follikelstimul.Hormon) | mIE/ml | - | MATERIAL: Serum/Vollblut, METHODE: CMIA | ||
FSME | FSME IgG | - | MATERIAL: Serum/Vollblut, ELISA | |||
FSMEM | FSME IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
FSMEQUANT | FSME IgG Impftiter | U/ml | - | MATERIAL: Serum/Vollblut, ELISA, Impfschutz >200 U/ml | ||
FT3 | FT3 (Freies Trijodthyronin) | pmol/l | 2.500 | - | 6.700 | MATERIAL: Serum/Vollblut, METHODE: CMIA |
FT4 | FT4 (Freies Thyroxin) | pmol/l | 10.30 | - | 21.90 | MATERIAL: Serum/Vollblut, METHODE: CMIA |
FT42 | FT4 nach TRH | pmol/l | - | MATERIAL: Serum/Vollblut, METHODE: CMIA | ||
FX1 | FX1 Nüsse | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX13 | FX13 Gemüsemix 1 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX15 | FX15 Obstmix 1 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX16 | FX16 Obstmix 2 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX2 | FX2 Fischmix 1 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX20 | FX20 Getreidemix 2 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX21 | FX21 Obstmix 4 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX29 | FX29 Obstmix 5 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX3 | FX3 Getreide | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX5 | FX5 Kindernahrung | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX70 | FX70 Gewürzemix 1 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX71 | FX71 Gewürzemix 2 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX72 | FX72 Gewürzemix 3 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX73 | FX73 Fleischmix | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FX74 | FX74 Fischmix 2 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
FXaAKTdir | Anti-Fak.Xa-Aktiv. direkt | ng/ml | - | MATERIAL: Citrat, METHODE: koagulometrisch | ||
FXaAKTind | Anti-Fak.Xa-Aktiv. dir/indir | U/ml | - | MATERIAL: Citrat, METHODE: koagulometrisch | ||
G1 | G1 Ruchgras | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G12 | G12 Roggen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G13 | G13 Honiggras (wolliges) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G14 | G14 Hafer | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G15 | G15 Weizen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G201 | G201 Gerste | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G202 | G202 Mais | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G212 | G212 rPhl p 12 Lieschgras | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G213 | G213 rPhl p 1/5 Lieschgras | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G214 | G214 rPhl p 7/12 Lieschgras | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G3 | G3 Knäuelgras | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G4 | G4 Wiesenschwingel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G5 | G5 Lolch | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G6 | G6 Lieschgras | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G6PDHERY | Glucose-6-PDH (Ery) | U/10^12 Ery | 221.00 | - | 570.00 | MATERIAL: EDTA, Methode: enzymatisch |
G6PDHHB | Glucose-6-PDH (Hb) | U/g Hb | 8.00 | - | 13.00 | MATERIAL: EDTA, Methode: enzymatisch |
G7 | G7 Schilf | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G70 | G70 Haargerste | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
G8 | G8 Wiesenrispengras | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
GABAPENTIN | Gabapentin | ug/ml | 2.00 | - | 20.00 | MATERIAL: Serum; METHODE: HPLC |
GABAU | Gamma-aminobuttersre /g Kr i.H. | umol/g Krea | 1.500 | - | 5.000 | MATERIAL: 2.Morgenharn Methode: LC-MS |
GAD | Glutamat-Decarboxylase AK | U/ml | 0.0 | - | 10.0 | MATERIAL: Serum; Methode: EIA |
GALL | Gallensäuren | umol/l | 0.000 | - | 10.000 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
GALLST | Gallensäuren i.St. | umol/g | 2.000 | - | 9.000 | MATERIAL: Stuhl, METHODE: photometrisch |
GAMMA | Gamma | % | 11.10 | - | 18.80 | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese |
GAMMAA | Gamma | g/dl | 0.800 | - | 1.350 | |
GASTRIN | Gastrin | uU/ml | 13.0 | - | 115.0 | MATERIAL: Serum/Vollblut, SPEZ.PRÄANALYTIK !! |
GASTROENT | BLOCK GASTROENTERITIS | - | ||||
GE | Gesamteiweiß | g/dl | - | MATERIAL: Serum/Vollblut, METHODE: photometrisch | ||
GE90 | P-AK: Wellensittichprot. IgG-AK | mg/l | < | 11.000 | MATERIAL: Serum, METHODE: FEIA | |
GE91 | P-AK: Tauben-Serum,Feder,Kot | mg/l | 0.000 | - | 10.000 | MATERIAL: Serum, METHODE: ELISA, |
GE92 | P-AK: Papagei-Serum,Feder,Kot | mg/l | 0.000 | - | 10.000 | MATERIAL: Serum, METHODE: ELISA, |
GE93 | P-AK: Taubenserum | mg/l | 0.000 | - | 10.000 | MATERIAL: Serum, METHODE: ELISA, |
GELBFIEBG | Gelbfieber-Virus IgG IIF | Titer | - | MATERIAL: Serum/Vollblut, METHODE: IIF | ||
GELBFIEBM | Gelbfieber-Virus IgM IIF | Titer | - | MATERIAL: Serum/Vollblut, METHODE: IIF | ||
GENTA | Gentamycin | ug/ml | 0.50 | - | 10.00 | MATERIAL: Serum/Vollblut; METHODE: FPIA |
GEP | Gesamteiweiß im Punktat | g/dl | - | MATERIAL: Punktat, METHODE: photometrisch | ||
GERIATRIE | Laborprofil GERIATRIE | - | ||||
GFR | Glom. Filtrationsrate (MDRD) | ml/min/1,73m2 | - | |||
GGRAD | Gradient im Gamma Bereich | % | - | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese | ||
GGRADA | Gradient in Gammabereich | g/dl | - | |||
GGT | Gamma - GT | U/l | 9.0 | - | 64.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
GHBH | GHB (Liquid Ecstasy) i.H. | mg/l | 0.00 | - | 5.00 | MATERIAL: Spontanharn, METHODE: CEDIA |
GLUCAN | Glucan beta-D | pg/ml | 0.0 | - | 79.0 | MATERIAL: Serum, METHODE: LAL |
GLUK | Glukagon | pg/ml | 0.0 | - | 209.0 | MATERIAL: EDTA-Plasma gefroren, Methode: RIA |
GLUP | Glukose im Punktat | mg/dl | - | MATERIAL: Punktat, METHODE: photometrisch | ||
GLYPHOSAT | Glyphosat | ug/l | < | 0.10 | MATERIAL: Serum, METHODE: GC-MS | |
GM22 | P-AK: Micropolyspora faeni | mg/l | 0.000 | - | 10.000 | MATERIAL: Serum, METHODE: ELISA |
GM24 | P-AK: Stachybotrys atra | mg/l | 0.000 | - | 10.000 | MATERIAL: Serum, METHODE: ELISA |
GM42 | P-AK: Laceyella saccari | mg/l | 0.000 | - | 21.500 | MATERIAL: Serum, METHODE: ELISA |
GO | Gonokokken KBR | - | MATERIAL: Serum, METHODE: KBR | |||
GOPCRAB | Gonokokken DNA (PCR) i.Abstr. | - | MATERIAL: Abstrich; Methode: PCR | |||
GOPCRU | Gonokokken DNA (PCR) i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
GOT | GOT | U/l | 5.0 | - | 34.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
GPT | GPT | U/l | 0.0 | - | 55.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
GSH | Glutathion (reduziert) | umol/l | 500.0 | - | 1500.0 | MATERIAL: CPDA-Röhrchen Methode: |
GSHGES | Glutathion Gesamt | umol/l | 500.0 | - | 1500.0 | |
GSHQ | Glutathion GSH/GSSG Ratio | - | ||||
GSHSTOFFW | Glutathion Stoffwechsel Profil | - | ||||
GSP | Glutathionperoxidase | U/g Hb | 27.50 | - | 73.60 | MATERIAL: EDTA, Methode: Photometrisch |
GSR | Glutathionreduktase | umol/l | - | MATERIAL: EDTA, Methode: | ||
GSSG | Glutathion (oxidiert) | umol/l | 100.000 | - | 500.000 | MATERIAL: spez. Abnahme - CPDA Methode: |
GSTATF | Profil Gerinnungsstatus | - | ||||
GX1 | GX1 Gräser (Frühbl.) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
GX2 | GX2 Gräsermix 1 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
GX3 | GX3 Gräsermix 2 GX3 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
GX4 | GX4 Gräser (Spätbl.) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
H1 | H1 Greer | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
H1N1v | H1N1v-RNA (PCR) | - | MATERIAL: Serum/Vollblut, METHODE: PCR | |||
H2 | H2 Hollister-Stier-Labs | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
HAEMBAK | Haem.influenzae Typ B IgG | mg/l | - | MATERIAL: Serum/Vollblut | ||
HALO | Haloperidol | ng/ml | 1.000 | - | 10.000 | MATERIAL: Serum/Vollblut, METHODE: LD-MS |
HÄMOPEXIN | Hämopexin | g/l | 0.500 | - | 1.150 | MATERIAL: Serum/Vollblut, METHODE: nephelometrisch |
HANTAG | Hantavirus IgG | - | MATERIAL: Serum; Methode: EIA | |||
HANTAM | Hantavirus IgM | - | MATERIAL: Serum; Methode: EIA | |||
HANTBLOTG | Hantavirus IgG-Ak (Blot) | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
HANTBLOTM | Hantavirus IgM-Ak (Blot) | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
HAPTO | Haptoglobin | mg/dl | 30.0 | - | 200.0 | MATERIAL: Serum/Vollblut, METHODE: Immunologischer Trübungstest |
HARN | Harn komplett | - | ||||
HAV | HAV - Antikörper (IgG) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HAVM | HAV - Antikörper (IgM) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HAVPCR | HAV - RNA (PCR) | - | MATERIAL: Serum/Vollblut, METHODE: PCR | |||
HAVQUANT | Hep.A Impftiter | - | MATERIAL: Serum/Vollblut, METHODE: MEIA, | |||
HB | Hämoglobin | g/dl | 12.00 | - | 18.00 | MATERIAL: EDTA, |
HBA1 | Hämoglobin A1c | % | 4.80 | - | 5.90 | MATERIAL: EDTA, METHODE: CMIA |
HBA1CALC | Hämoglobin A1c (IFCC) | mmol/mol | 29.0 | - | 40.0 | MATERIAL: EDTA-Blut, METHODE: |
HBA1M | Hämoglobin A1c (IFCC) | mmol/mol | 29.00 | - | 39.00 | MATERIAL: EDTA, METHODE: CMIA |
HBCAK | HBc - Antikörper (IgG) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBCM | HBc - Antikörper (IgM) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBDH | HBDH | U/l | 44.0 | - | 168.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
HBEAG | HBe - Antigen | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBEAK | HBe - Antikörper | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBELPH | Hb-Elektrophorese | - | MATERIAL: EDTA, METHODE: Elektrophorese | |||
HBEPA | Hämoglobin A | % | - | MATERIAL: EDTA, METHODE: Elektrophorese | ||
HBEPA2 | Hämoglobin A2 | % | - | MATERIAL: EDTA, METHODE: Elektrophorese | ||
HBEPF | Hämoglobin F | % | - | MATERIAL: EDTA, METHODE: Elektrophorese | ||
HBEPTX | HB Elphor Beurteilung: | - | MATERIAL: EDTA, METHODE: Elektrophorese | |||
HBILI | Harnbilirubin | mg/dl | - | MATERIAL: Spontanharn, METHODE: STIX | ||
HBSAG | HBs - Antigen | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBSAGbest | HBsAg-Bestätigungstest | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HBSAK | HBs - Antikörper | mIU/ml | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | ||
HBSQUANT | Hep.B Impftiter | mIU/ml | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | ||
HBVPCRVL | Hepatitis B PCR Viral load | IU/ml | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: PCR |
HCG | HCG | mIE/ml | 0.00 | - | 5.00 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
HCV | HCV-AK (IgG+IgM) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HCVBEST | HCV-AK (IgG Bestätigung) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HCVGENO | HCV - Genotyp | - | MATERIAL: Serum/Vollblut, METHODE:LiPA | |||
HCVPCR | HCV - RNA (PCR) | - | MATERIAL: Serum/Vollblut, METHODE: PCR | |||
HCVPCRVL | Hepatitis C PCR Viral load | IU/ml | - | MATERIAL: Serum, METHODE: PCR | ||
HDL | HDL-Cholesterin | mg/dl | 40.0 | - | 68.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
HDVG | HDV IgG Antikörper | - | MATERIAL: Serum/Vollblut | |||
HDVM | HDV IgM Antikörper | - | MATERIAL: Serum/Vollblut | |||
HDVPCR | HDV - RNA (PCR) | - | MATERIAL: Serum/Vollblut | |||
HDVSCREEN | HDV-Antikörper (IgG + IgM) | - | MATERIAL: Serum/Vollblut | |||
HE4 | HE4 (Hum.Epidid.Prot.4) | pmol/l | 0.00 | - | 104.00 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
HEINZ | Heinz'sche Innenkörper | - | MATERIAL: EDTA, METHODE: Mikroskopie | |||
HEROINH | Heroin/6-AM (U) | - | MATERIAL: Spontanharn, METHODE: CEDIA | |||
HEVG | HEV-Ak IgG | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HEVM | HEV-Ak IgM | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HEVPCR | HEV - RNA (PCR) | - | MATERIAL: Serum/Vollblut, METHODE: PCR | |||
HEW | Harneiweiß | mg/dl | - | MATERIAL: Spontanharn, METHODE: STIX | ||
HEXANU | 2,5-Hexandion i.H. | mg/l | 0.00 | - | 0.90 | MATERIAL: Spontanharn, METHODE: GC-MS |
HFE | Hämochromatosescreening | - | MATERIAL: EDTA, METHODE: PCR | |||
HGEG | A. phagocytophilum IgG | 0.0 | - | 64.0 | MATERIAL: Serum; Methode: IFT | |
HGEM | A. phagocytophilum IgM | 0.0 | - | 20.0 | MATERIAL: Serum; Methode: IFT | |
HGH | HGH/STH | µg/l | 0.000 | - | 13.400 | MATERIAL: Serum/Vollblut, METHODE: LIA |
HHV6G | Humanes Herpesvirus 6 IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | |||
HHV6M | Humanes Herpesvirus 6 IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | |||
HHV8G | Humanes Herpesvirus Typ 8 IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | |||
HIPA | Heparin induz. Plättchenaggreg. | - | MATERIAL: Serum, METHODE: HIPA-Test | |||
HIST | Histamin | ug/l | < | 1.980 | MATERIAL: EDTA-Plasma | |
HISTO | Histologischer Befund | - | MATERIAL: Gewebeprobe | |||
HISTST | Histamin i.St. | ug/l | < | 959.0 | MATERIAL: Stuhl, METHODE: EIA | |
HIT | Hep.-induz. Thrombozytopenie | - | ||||
HIV | HIV 1/2 AG/AK (Suchtest) | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HIVAG | HIV 1 Antigen (Suchtest) | - | MATERIAL: Serum/Vollblut ;METHODE:CMIA | |||
HIVAGBEST | HIV 1 Antigen (Referenztest) | - | MATERIAL: Serum/Vollblut ;METHODE:CMIA | |||
HIVAKBLOT | HIV Ak BLOT (Referenztest) | - | MATERIAL: Serum/Vollblut ;METHODE:CMIA | |||
HIVMKP | HIV 1/2 AG/AK MKP | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
HIVPCRVL | HIV PCR Viral load | Kopien/ml | - | MATERIAL: EDTA , Methode: PCR | ||
HIVRES | HIV Resistenz | - | MATERIAL: EDTA, | |||
HIVZWEIT | HIV 1/2 Ak (Zweittest) | - | MATERIAL: Serum/Vollblut ;METHODE:CMIA | |||
HK | Hämatokrit | % | 37.00 | - | 54.00 | MATERIAL: EDTA, |
HLAB27 | HLA B27 Screening | - | MATERIAL: EDTA, METHODE: Durchflusszytometrie | |||
HLAB27G | HLA B27 molekulargen.Typ | - | MATERIAL: EDTA, | |||
HLAB51 | HLA B51 | - | MATERIAL: EDTA, METHODE: SSO (spezielle PCR) | |||
HLADQ2 | HLADQ2 | - | MATERIAL: EDTA, METHODE: PCR | |||
HLADQ7 | HLADQ7 | - | MATERIAL: EDTA, METHODE: | |||
HLADQ8 | HLADQ8 | - | MATERIAL: EDTA, METHODE: PCR | |||
HLADR | HLA-DR | - | MATERIAL: EDTA, METHODE: SSO und SSP (spezielle PCR) | |||
HLPABS | Helferzellen absolut | /mm3 | 410.0 | - | 1590.0 | MATERIAL: EDTA, METHODE: Flow cytometrie |
HLPREL | Helferzellen relativ | % | 29.0 | - | 58.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |
HMA | Herzmuskel-AK | Titer | 0.0 | - | 100.0 | MATERIAL: Serum/Vollblut |
HOCY | Homocystein | umol/l | 0.00 | - | 12.00 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
HOLOTC | Holotranscobalamin | pmol/l | 37.50 | - | 188.00 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
HOMA | HOMA - Index | - | ||||
HPATH | Harn auf pathogene Keime | - | MATERIAL: Spontanharn, METHODE: Kultur | |||
HPROLIN | Hydroxyprolin | umol/l | 0.0 | - | 50.0 | MATERIAL:Serum/Vollblut,spez.Präanalytik!METHODE:HPLC |
HPROLINH | Hydroxyprolin/mol Krea i.24h H. | mmol/mol Kreat | 0.000 | - | 13.000 | MATERIAL: 24h Harn, METHODE: HPLC |
HPYL | Helicobacter pylori IgG | U/ml | 0.000 | - | 0.890 | MATERIAL: Serum/Vollblut, METHODE: LIA |
HPYLST | Helicobacter pyl.AG i.St. | - | MATERIAL: Stuhl, METHODE: ELISA | |||
HPYRENU | 1-Hydroxypyren i.H. | ug/l | 0.000 | - | 0.500 | MATERIAL: Spontanharn, METHODE: HPLC |
HPYRENUKR | 1-Hydroxypyren /g Krea i.H. | ug/g Krea | 0.00 | - | 0.30 | MATERIAL: Spontanharn, METHODE: HPLC |
HSPEZ | Spez. Gewicht (U) | 1.0050 | - | 1.0300 | MATERIAL: Spontanharn, METHODE: Refraktometer | |
HSR | Harnsäure | mg/dl | 2.00 | - | 7.20 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
HSRH | Harnsäure i.24h H. | mg/24h | 0.0 | - | 800.0 | MATERIAL: 24h-Sammelharn, METHODE: photometrisch |
HSRP | Harnsäure im Punktat | mg/dl | 2.00 | - | 7.00 | MATERIAL: Punktat, METHODE: photometrisch |
HSRU | Harnsäure i.H. | mg/dl | - | MATERIAL: Spontanharn, METHODE: photometrisch | ||
HSS | Hep.B-Serologie | - | ||||
HST | Harnstoff | mg/dl | 18.0 | - | 50.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
HSU | Hippursäure i.H. | mg/l | 0.0 | - | 1500.0 | MATERIAL: Spontanharn, METHODE: HPLC |
HSV | H.simplex 1/2 IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
HSV1PCR | H.simplex 1 DNA (PCR) | - | MATERIAL: EDTA, METHODE: PCR | |||
HSV2G | H.simplex 2 IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
HSV2PCR | H.simplex 2 DNA (PCR) | - | MATERIAL: EDTA, METHODE: PCR | |||
HSVM | H.simplex 1/2 IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
HUMANFGF23 | Humanes FGF-23-c-terminal | kRU/l | 26.00 | - | 110.00 | MATERIAL: EDTA-Blut; METHODE: ELISA |
HVSH | Homovanillinsäure i.24h H. | mg/24h | 1.82 | - | 6.92 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
HX1 | HX1 Hausstaub | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
HYDROMORPH | Hydromorphon | ug/l | 5.0 | - | 15.0 | MATERIAL: Serum; Methode: LC-MS |
HYDROXYZIN | Hydroxyzin | ng/ml | 30.00 | - | 90.00 | MATERIAL: Serum; METHODE: LC-MS |
HZ | Harnzucker | mg/dl | 0.0 | - | 499.0 | MATERIAL: Spontanharn, METHODE: STIX/photometrisch |
I1 | I1 Biene | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I204 | I204 Bremse Tabanus spp. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I205 | I205 Hummel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I208 | I208 rApi m 1 Biene | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I209 | I209 rVes v 5 Wespe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I211 | I211 rVes v 1 Wespe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I214 | I214 rApi m 2 Biene | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I215 | I215 rApi m 3 Biene | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I216 | I216 rApi m 5 Biene | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I217 | I217 rApi m 10 Biene | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I3 | I3 Wespe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I4 | I4 Papierwespe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I6 | I6 Küchenschabe | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I70 | I70 Feuerameise | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I71 | I71 Stechmücke | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I73 | I73 Rote Mückenlarve | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
I75 | I75 Hornisse | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
IA2 | IA2 (Tyrosin-Phosphatase-Ak) | U/ml | 0.00 | - | 10.00 | MATERIAL: Serum; Methode: EIA |
IBUPROFEN | Ibuprofen | mg/l | - | MATERIAL: Serum, METHODE: HPLC | ||
ICAEIA | Inselzell-AK (GAD/IA2) EIA | U/ml | 0.0 | - | 20.0 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
ICAIFT | Inselzell-AK (IFT) | Titer | 0.0 | - | 10.0 | MATERIAL: Serum/Vollblut, METHODE: Immunfluoreszenz |
ICSAK | Interzell. Subst.-Ak | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
ICTP | ICTP Kollagen I Telopeptid | ug/l | - | MATERIAL: Serum METHODE: | ||
I-FABP | Intest.-fatty acid binding prot | pg/ml | < | 1827.0 | MATERIAL: Serum, METHODE: ELISA | |
IFE_S | Immunfixation | - | MATERIAL: Serum/Vollblut, METHODE: IFE/Kapillarelphor | |||
IFNGAMMA | Interferon gamma | pg/ml | 0.00 | - | 38.60 | MATERIAL: Serum, METHODE: LC-MS |
IGA | Immunglobulin-A | mg/dl | 70.00 | - | 400.00 | MATERIAL: Serum/Vollblut, METHODE: turbidimetrisch |
IgAsekST | sekr. Immunglobulin A i.St. | ug/g St. | 100.00 | - | 1200.00 | MATERIAL: Stuhl |
IGD | Immunglobulin-D | mg/l | 0.0 | - | 152.0 | MATERIAL: Serum/Vollblut |
IGE | Immunglobulin-E | U/ml | 0.000 | - | 100.000 | MATERIAL: Serum/Vollblut, METHODE: LIA |
IGF1 | IGF-1/Somatomedin C | ng/ml | 15.00 | - | 564.00 | MATERIAL: Serum/Vollblut, METHODE: CLIA |
IGFBP3 | IGF-Bindungsprotein 3 | ng/ml | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | ||
IGG | Immunglobulin-G | mg/dl | 540.00 | - | 1822.00 | MATERIAL: Serum/Vollblut, METHODE: turbidimetrisch |
IGG_SUB | IgG Subklassen 1-4 | - | MATERIAL: Serum 5 ml; Methode: Nephelom. | |||
IGG1 | IgG 1 | mg/l | - | MATERIAL: Serum 5 ml; Methode: Nephelom. | ||
IGG2 | IgG 2 | mg/L | - | MATERIAL: Serum 5 ml; Methode: Nephelom. | ||
IGG3 | IgG 3 | mg/l | - | MATERIAL: Serum 5 ml; Methode: Nephelom. | ||
IGG4 | IgG 4 | mg/l | - | MATERIAL: Serum 5 ml; Methode: Nephelom. | ||
IGGSub | IgG Subklassen 1-4 | - | ||||
IGM | Immunglobulin-M | mg/dl | 40.00 | - | 230.00 | MATERIAL: Serum/Vollblut, METHODE:turbidimetrisch |
IL-10 | Interleukin 10 | pg/ml | 0.00 | - | 9.00 | MATERIAL: EDTA, METHODE: LIA |
IL-1BETA | Interleukin 1 Beta | pg/ml | 0.0 | - | 5.0 | MATERIAL: Serum, METHODE: EIA |
IL-2 | Interleukin 2 | pg/ml | 0.000 | - | 5.000 | MATERIAL: EDTA-Plasma gefroren, METHODE: CLIA |
IL2REZ | Lösl. Interleukin 2 Rezeptor | U/ml | 158.0 | - | 623.0 | MATERIAL: Serum/Vollblut METHODE: CLIA |
IL-6 | Interleukin 6 | pg/ml | 0.00 | - | 7.00 | MATERIAL: Serum, METHODE: ECLIA |
IL-8 | Interleukin 8 | pg/ml | 0.00 | - | 61.00 | MATERIAL: EDTA, METHODE: LIA |
IMMUNK | Zirkulierende Immunkomplexe | ug/ml | 0.000 | - | 44.000 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
IMMUNS | Lympho-Phänotypisierung | - | Material: EDTA, Methode: Flow Cytometrie | |||
IMMUNSHUM | Humoraler Immunstatus | - | MATERIAL: Serum/Vollblut | |||
INFLA | Influenza A KBR | Titer | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE: KBR |
INFLAA | Influenza A IgA | Ratio | 0.000 | - | 0.800 | MATERIAL: Serum/Vollblut, METHODE: IFT |
INFLAG | Influenza A IgG | RE/ml | 0.0 | - | 16.0 | MATERIAL: Serum/Vollblut, METHODE: IFT |
INFLB | Influenza B KBR | Titer | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE: KBR |
INFLBA | Influenza B IgA | Ratio | 0.000 | - | 0.800 | MATERIAL: Serum/Vollblut, METHODE: IFT |
INFLBG | Influenza B IgG | RE/ml | 0.0 | - | 16.0 | MATERIAL: Serum/Vollblut, METHODE: IFT |
INFLIXI | Infliximab | ug/ml | 3.000 | - | 7.000 | MATERIAL: Serum, METHODE: EIA |
INFLIXIAK | Infliximab Antikörper | AU/ml | 0.00 | - | 10.00 | MATERIAL: Serum; METHODE: EIA |
INFLPCR | Influenza A-/B-PCR | - | MATERIAL: Nasensekret, METHODE: PCR | |||
INHIBINA | Inhibin A (Dimer) | pg/ml | - | MATERIAL: Serum, METHODE: | ||
INHIBINB | Inhibin B | ng/l | - | MATERIAL: Serum/Vollblut, METHODE: | ||
INR | PT/INR (int.normalized ratio) | - | MATERIAL: Citrat, METHODE: kalkulatorisch | |||
INSUL | Insulin | mU/l | 2.60 | - | 24.90 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
INSULG | Insulin-AK IgG | U/ml | 0.00 | - | 9.90 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
INTRFAKA | Intrinsic Faktor AK | RATIO | 0.000 | - | 1.000 | MATERIAL: Serum/Vollblut, METHODE: Immunfluoreszenz |
INTRFAKAW | Intrinsic Faktor AK | RATIO | - | MATERIAL: Serum/Vollblut, METHODE: Immunfluoreszenz | ||
ITRACO_GES | Itraconazol+Hydroxyitraconazol | mg/l | 230.000 | - | 450.000 | MATERIAL: Serum, METHODE: Berechnet |
JAK2_EXON | JAK2 Exon12 Mutationsnachweis | - | MATERIAL: EDTA 5ml; Methode: PCR | |||
JAK2_V617F | JAK2 V617F Mutationsnachweis | - | MATERIAL: EDTA 5ml; Methode: PCR | |||
JAPENZEPHG | Japan.-Enz.-Virus IgG | Titer | 0.0 | - | 20.0 | MATERIAL: Serum, METHODE: IFT |
JCVPCR | JC-Polyomavirus DNA (PCR) | - | MATERIAL: EDTA-Blut; METHODE: PCR | |||
JO1 | Jo-1 | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
JODS | Jod im Serum | ug/l | 40.00 | - | 80.00 | MATERIAL: Serum; Methode: ICP-MS |
JODU | Jod i.H. | ug/l | 100.00 | - | 200.00 | MATERIAL: Spontanharn; Methode: ICP-MS |
JODUKR | Jod /g Krea i.H. | ug/g Krea | - | Material: Spontanharn; Methode: ICP-MS | ||
JUGA | Jugendliche Neutrophile (abs.) | /µl | - | |||
K | Kalium | mmol/l | 3.000 | - | 5.400 | MATERIAL: Serum/Vollblut, METHODE: ISE |
K20 | K20 Schafwolle | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K201 | K201 Papain | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K202 | K202 Bromelin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K208 | K208 nGal d 4 Ei-Lysozym | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K503 | K503 Aloe Vera | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K616 | K616 Jod | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K628 | K628 Nickel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K73 | K73 Wildseide | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K74 | K74 Naturseide | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K75 | K75 Isocyanat TDI+ | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K75G | P-AK: Isozyanat TDI IgG-AK | mg/l | - | MATERIAL: Serum, METHODE: FEIA | ||
K76 | K76 Isocyanat MDI+ | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K76G | P-AK: Isozyanat MDI IgG-AK | mg/l | - | MATERIAL: Serum, METHODE: FEIA | ||
K77 | K77 Isocyanat HDI+ | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K77G | P-AK: Isozyanat HDI IgG-AK | mg/l | - | MATERIAL: Serum, METHODE: FEIA | ||
K79 | K79 Pthalsäure Anhydrid+ | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K80 | K80 Formaldehyd+ | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K81 | K81 Ficus spp. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K82 | K82 Latex (Hevea brasil.) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K83 | K83 Baumwollsamen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K84 | K84 Sonnenblumensamen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K86 | K86 Trimellitsre-Anhydrid | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K87 | K87 Alpha-Amylase | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
K93 | K93 Ammoniumpersulfat | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
KAPPA | Kappa | mg/dl | 156.00 | - | 408.00 | MATERIAL: Serum/Vollblut, METHODE: turbidimetrisch |
KAPPAfreiS | Freies KAPPA im Serum | mg/l | 3.30 | - | 19.40 | MATERIAL: Serum, METHODE: turbidimetrisch |
KAPPAfreiU | Freies KAPPA i.H. | mg/l | 0.00 | - | 24.20 | MATERIAL: Harn, METHODE: turbidimetrisch |
KARDIOTROP | Kardiotrope Erreger | - | MATERIAL: Serum/Vollblut, METHODE: diverse | |||
KECHIR1 | KET-Chirurgie 1.Postop.Tag | - | ||||
KECHOL1 | KET-Cholezystekt 1.Postop.Tag | - | ||||
KECOVID | KET-COVID | - | ||||
KECOVIDSUB | KET-COVID Subblock | - | ||||
KEGEBHLP | KET-GebHilfe HELLP | - | ||||
KEICU | KET-ICU | - | ||||
KEIMZAHL | Keimzahl | - | MATERIAL: Bakt.Probe | |||
KEINT | KET-Interne Routine | - | ||||
KEINTKO | KET-Interne Kontrolle Routine | - | ||||
KELLAG | Kell Antigen | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
KENCHPRAE | KET-NeuroChir Rout prä | - | ||||
KENEURO | KET-Neurologie | - | ||||
KEOSTEO | KET-Osteoporose | - | ||||
KEPSYCHGW | KET-Labor Dr.Ghedina Walter | - | ||||
KEPSYCHKN | KET-Labor Dr.Kaufmann-Riegler | - | ||||
KEPSYKNSU1 | KET-Labor Dr.Kaufmann Sub1 | - | ||||
KEPSYKNSU2 | KET-Labor Dr.Kaufmann Sub2 | - | ||||
KEPSYKNSU3 | KET-Labor Dr.Kaufmann Sub3 | - | ||||
KESPON1 | KET-Spondylo 1.postop | - | ||||
KESPON4 | KET-Spondylo 4.postop | - | ||||
KESTRUM1 | KET-Struma 1.postop | - | ||||
KESTRUM2 | KET-Struma 2.postop | - | ||||
KESUB1 | KET-Subgruppe 1 | - | ||||
KESUB2 | KET-Subgruppe 2 | - | ||||
KESUB3 | KET-Subgruppe 3 | - | ||||
KESUB4 | KET-Subgruppe 4 | - | ||||
KESUBNEUR1 | KET-Subgruppe Neuro 1 | - | ||||
KESUBNEURO | KET-Subgruppe Neuro | - | ||||
KET | Ketonkörper | mg/dl | - | MATERIAL: Spontanharn, METHODE: STIX | ||
KETAMINH | Ketamin (U) | µg/l | 0.00 | - | 10.00 | MATERIAL: Spontanharn; METHODE: |
KETONS | Ketone im Serum | - | ||||
KETU | KET-TU Suche Abklärung | - | ||||
KEUNF1 | KET-Unfall 1. postop | - | ||||
KEUNFPRAE | KET-Unfall Routine prä | - | ||||
KH | Kalium i.24h H. | mmol/24h | 25.000 | - | 125.000 | MATERIAL: 24h-Sammelharn, METHODE: ISE |
KLBB | Kleines Blutbild | - | MATERIAL: EDTA | |||
KLQ | Kappa-lambda-Quotient | 1.29 | - | 2.61 | MATERIAL: Serum | |
KOKS | Kokain im Serum | ug/l | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: FPIA |
KOLLA | Kollagen-AK | U/ml | 0.30 | - | 0.80 | MATERIAL: Serum/Vollblut |
KREAT | Kreatinin | mg/dl | 0.100 | - | 1.300 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
KREAU | Kreatinin i.H. | mg/dl | 28.00 | - | 270.00 | MATERIAL: Spontanharn, METHODE: photometrisch |
KREAU_AM | Kreatinin i.H. (Arbeitsmed.) | g/l | 0.400 | - | 2.780 | MATERIAL: Spontanharn, METHODE: photometrisch |
KREAUMDA | Kreatinin i.H. (MDA) | mg/dl | 40.00 | - | 278.00 | MATERIAL: Spontanharn, METHODE: photometrisch |
KRH | Kreatinin i.24h H. | g/24h | 0.800 | - | 2.500 | MATERIAL: 24h-Sammelharn, METHODE: photometrisch |
KRYPTH | Kryptopyrrol /g Krea i.H. | mg/g Krea | < | 5.000 | Material: Spontanharn, spez. Abnahme erforderlich | |
KV | Kalium i.Vollblut (Li-Heparin) | mmol/l | 37.70 | - | 44.30 | MATERIAL: Li-Heparin, METHODE: AAS |
LA | La (SS-B) | - | MATERIAL: Serum/Vollblut, METHODE:Immunoblot | |||
LA1 | Lupus-Ak-Screening (DRVVT) | sec | 31.0 | - | 41.0 | MATERIAL: Citrat, |
LA2 | Lupus-Ak-Bestätigung (SCT) | sec | 31.0 | - | 41.0 | MATERIAL: Citrat, |
LACOSAMID | Lacosamid | ug/ml | 1.00 | - | 10.00 | MATERIAL: Serum/Vollblut METHODE: |
LACTAT | Lactat | mg/dl | 4.50 | - | 19.80 | MATERIAL: Fluorid-Plasma, METHODE: photometrisch |
LACTOFAK | AK gegen Lactoferrin | U/ml | 0.0 | - | 9.9 | MATERIAL: Serum, METHODE: EIA |
LACTOFST | Lactoferrin i.St. | ug/g Stuhl | 0.000 | - | 7.240 | MATERIAL: Stuhl |
LAKTGEN | Hered.Laktoseintoleranz (LCT) | - | MATERIAL: EDTA; Methode: Gentest | |||
LAMBAG | Lamblien Erregernachweis i.St. | - | MATERIAL: Stuhl, METHODE: mikrosk.Nachw.i.Frischpräp. | |||
LAMBDA | Lambda | mg/dl | 83.00 | - | 224.00 | MATERIAL: Serum/Vollblut, METHODE:turbidimetrisch |
LAMBDfreiS | Freies LAMBDA im Serum | mg/l | 5.70 | - | 26.30 | MATERIAL: Serum, METHODE: turbidimetrisch |
LAMBDfreiU | Freies LAMBDA i.H. | mg/l | 0.00 | - | 6.70 | MATERIAL: Harn, METHODE: turbidimetrisch |
LAMBM | Lamblien/Giardia IgM | U/ml | 0.0 | - | 30.0 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
LAMO | Lamotrigin | ug/ml | 3.00 | - | 15.00 | MATERIAL: Serum/Vollblut, METHODE: HPLC |
LAP | LAP | U/l | 20.00 | - | 50.00 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
LAT | Rheumafaktor (RF) | U/ml | 0.000 | - | 14.000 | MATERIAL: Serum/Vollblut, METHODE: turbidimetrisch |
LCMG | LCM IgG | Titer | 0.0 | - | 16.0 | MATERIAL: Serum/Vollblut, METHODE: IFT |
LCMM | LCM IgM | Titer | 0.0 | - | 16.0 | MATERIAL: Serum/Vollblut, METHODE: IFT |
LDH | LDH | U/l | 110.0 | - | 243.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
LDH1 | LDH Isoenzym 1 | % | 16.10 | - | 31.50 | MATERIAL: Serum, METHODE: IFE |
LDH2 | LDH Isoenzym 2 | % | 29.20 | - | 41.60 | MATERIAL: Serum, METHODE: IFE |
LDH3 | LDH Isoenzym 3 | % | 17.00 | - | 26.20 | MATERIAL: Serum, METHODE: IFE |
LDH4 | LDH Isoenzym 4 | % | 5.90 | - | 12.30 | MATERIAL: Serum, METHODE: IFE |
LDH5 | LDH Isoenzym 5 | % | 3.20 | - | 17.30 | MATERIAL: Serum, METHODE: IFE |
LDHISO | LDH Isoenzyme | - | MATERIAL: Serum, METHODE: IFE | |||
LDHP | LDH im Punktat | U/l | - | MATERIAL: Punktat, METHODE: photometrisch | ||
LDL | LDL-Cholesterin | mg/dl | 0.0 | - | 116.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
LDL_DMP | LDL-Disease Management Programm | mg/dl | - | MATERIAL: Serum/Vollblut, METHODE: photometrisch | ||
LDL_MDA | LDL MDA-modifiziert | U/l | < | 70.00 | MATERIAL: Serum/Vollblut, METHODE: photometrisch | |
LDL_OX | LDL oxidiert | ng/ml | < | 133.20 | MATERIAL: Serum/Vollblut, METHODE: photometrisch | |
LDL_OXAK | LDL oxidiert-AK | - | MATERIAL: Serum/Vollblut, METHODE: | |||
LDLHDLRAT | LDL/HDL-Ratio | 0.00 | - | 3.50 | ||
LDLSUB | LDL-Subfraktionen (Lipoprint) | - | MATERIAL: Serum/Vollblut, METHODE: Gelelektrophorese | |||
LDOPA | Levodopa (L-Dopa) | mg/l | 0.900 | - | 2.000 | MATERIAL: EDTA-Plasma gefroren, METHODE: HPLC |
LEG | Legionellen AK | - | ||||
LEGAG | Legionellen i.Sputum | - | MATERIAL: Sputum; Methode: PCR | |||
LEGAGH | Legionellen i.H. | - | MATERIAL: Spontanharn; Methode: EIA | |||
LEGG | Legionella pneumophila IgG | - | MATERIAL: Serum/Vollblut, METHODE: EIA | |||
LEGM | Legionella pneumophila IgM | - | MATERIAL: Serum/Vollblut, METHODE: EIA | |||
LEGspezG | Leg.spezies IgG | Titer | 0.0 | - | 255.9 | MATERIAL: Serum/Vollblut, METHODE: IFT |
LEISHAK | Leishmanien IHA | - | MATERIAL: Serum/Vollblut, METHODE: IHA | |||
LEISHG | Leishmania donovani IgG-Ak | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
LEISHM | Leishmania donovani IgM-Ak | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
LEPTIN | Leptin | ng/ml | - | MATERIAL: Serum/Vollblut | ||
LEPTOG | Leptospira IgG | - | MATERIAL: Serum/Vollblut, METHODE: EIA | |||
LEPTOKBR | Leptospiren KBR | - | MATERIAL: Serum/Vollblut, METHODE: Agg./KBR | |||
LEPTOM | Leptospira IgM | - | MATERIAL: Serum/Vollblut, METHODE: EIA | |||
LEUKO | Leukozyten | G/l | 4.00 | - | 10.00 | MATERIAL: EDTA-Blut |
LEUKOH | Leukozyten i.H. | /ul | 0.0 | - | 0.1 | MATERIAL: Spontanharn |
LEUKOP | Leukozyten im Punktat | Zahl/ul | - | MATERIAL: Punktat | ||
LEVETIRA | Levetiracetam | mg/l | 10.00 | - | 40.00 | Material:Vollblut/Serum Methode:HPLC |
LEVOMEPROM | Levomepromazin | ng/ml | 30.00 | - | 160.00 | MATERIAL: Serum/Vollblut METHODE: |
LGI1AK | LGI1-AK (IgG) | Titer | 0.00 | - | 10.00 | MATERIAL: Serum, Methode: IFT |
LH | LH (Luteinisierungshormon) | mIE/ml | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | ||
LHFSHQ | LH-FSH-Quotient | - | MATERIAL: Spontanharn, METHODE: photometrisch | |||
LI | Lithium | mmol/l | - | MATERIAL: Serum/Vollblut, METHODE: ISE | ||
LIDOCAIN | Lidocain | mg/l | 1.00 | - | 5.00 | MATERIAL: Serum; METHODE: LC-MS/MS |
LIGNOCERIN | Lignocerinsäure C24:0 | umol/l | 25.0 | - | 90.0 | MATERIAL: Serum Methode: GC-MS |
LINDAN | Hexachlorcyclohexan (Lindan) | ug/l | < | 0.100 | MATERIAL: Spezialröhrchen, METHODE: GC-MS | |
LIP | Lipase | U/l | 8.0 | - | 78.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
LIPELPH | Lipidelphor | - | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese | |||
LIPONSRE | Liponsäure | ug/l | - | MATERIAL: Serum/Vollblut Methode: LC-MS | ||
LISDEXAMPH | Lisdexamphetamin | ug/l | 1.00 | - | 5.00 | MATERIAL: Serum; METHODE: GC-MS |
LIST | Listerien IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
LKM | LKM (liver/kidney/microsomes) | - | MATERIAL: Serum/Vollblut | |||
LOPERAMID | Loperamid | ug/l | 1.00 | - | 3.00 | MATERIAL: Serum; METHODE: LC-MS |
LORAZEPAM | Lorazepam | ug/l | 30.000 | - | 100.000 | MATERIAL: Serum, METHODE: LC-MS |
LPA | Lipoprotein (a) | nmol/l | 0.0 | - | 75.0 | MATERIAL: Serum/Vollblut, METHODE: Immunologischer Trübungstest |
LPOX | Lipidperoxidations-Produkte | umol/l | < | 300.000 | MATERIAL: Serum; Methode: HPLC | |
LPQ | Lactat-Pyruvat-Quotient | 0.0 | - | 10.0 | ||
LRP4AK | LRP4 Antikörper | - | MATERIAL: Serum, METHODE: IFT | |||
LSCR | Leber-AK Screening | - | MATERIAL: Serum, METHODE: IBLOT | |||
LSDH | LSD (U) | ng/ml | 0.000 | - | 0.500 | MATERIAL: Spontanharn; METHODE: EMIT |
LSDS | LSD (S) | ng/ml | 0.0 | - | 20.0 | MATERIAL: Serum/Vollblut; METHODE: FPIA |
LUP | Lupus eryth. Diagnostik | - | MATERIAL: Citrat, | |||
LY | Lymphozyten | % | 15.00 | - | 40.00 | MATERIAL: EDTA, |
LYMPHADVIR | BLOCK LYMPHADENITIS | - | ||||
LYMPHOA | Lymphozyten (abs.) | /µl | 1000.0 | - | 5500.0 | |
LYP | Lymphozyten | % | - | MATERIAL: Punktat | ||
LYSOS | Lysozym im Serum | mg/l | 3.00 | - | 12.00 | MATERIAL: Serum, METHODE: RADIM |
LYSOZYMST | Lysozym i.St. | ug/g Stuhl | 0.0 | - | 15.0 | MATERIAL: Stuhl, METHODE: ELISA |
M1 | M1 Penicillium not. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M11 | M11 Rhizopus nigricans | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M11G | P-AK: Rhizopus nigricans | mg/l | 0.000 | - | 8.000 | MATERIAL: Serum, METHODE: ELISA |
M12 | M12 Aureobasidiu pullulans | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M12G | P-AK: Aureobasidium pullulans | mg/l | 0.000 | - | 22.000 | MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK |
M13 | M13 Phoma betae | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M16 | M16 Curvularia lunata | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M1G | P-AK: Penicillium notatum IgG | mg/l | 0.000 | - | 27.000 | MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK |
M2 | M2 Cladosporium herb. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M207 | M207 Aspergillus niger | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M209G | P-AK: Penicillium glab. IgG-AK | mg/l | 0.000 | - | 21.000 | MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK |
M2GP | P-AK: Cladosporium herbarum IgG | mg/l | 0.000 | - | 39.000 | MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK |
M2PK | M2 Pyruvatkinase | U/ml | 20.30 | - | 42.50 | MATERIAL: EDTA Methode: |
M2PKST | M2 Pyruvatkinase i.St. | U/mg | 0.00 | - | 8.00 | MATERIAL: Stuhl Methode: |
M3 | M3 Aspergillus fumigatus | RAST-KL | - | MATERIAL: Serum, METHODE: LIA; spez.IgE-RAST | ||
M32G | P-AK: Cladosporium clad. IgG-AK | mg/l | 0.000 | - | 30.000 | MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK |
M3G | P-AK: Aspergillus fumigatus IgG | mg/l | 0.000 | - | 39.000 | MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK |
M4 | M4 Mucor rac. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M4G | P-AK: Mucor racemosus IgG | mg/l | 0.000 | - | 39.000 | MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK |
M5 | M5 Candida Albicans | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M5G | P-AK: Candida albicans IgG | mg/l | 0.000 | - | 39.000 | MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK |
M6 | M6 Alternaria alt. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M6G | P-AK: Alternaria alternata IgG | mg/l | 0.000 | - | 39.000 | MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK |
M7 | M7 Botrytis cinerea | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M8 | M8 Helminthosp. halodes | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M9 | M9 Fusarium species | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M9G | P-AK: Fusarium prolifer. IgG-AK | mg/l | 0.000 | - | 15.000 | MATERIAL: Serum, METHODE: ELISA; präz.IgG-AK |
MAGM | Myelin assoz.Glycoprot. IgM-AK | Titer | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: IFT |
MAKROS | Makroskopische Beschreibung | - | MATERIAL: Sputum | |||
MALAR | Malaria - Nachweis | - | MATERIAL: EDTA, METHODE: Mikroskopie | |||
MAPROTILIN | Maprotilin | ng/ml | 75.00 | - | 130.00 | MATERIAL: Serum/Vollblut METHODE: LC-MS |
MB | Morphologie im Diff.BB | - | MATERIAL: EDTA, METHODE: Mikroskopie | |||
MBL | Mannose-bindendes-Lektin | ng/ml | > | 540.0 | MATERIAL: Serum, METHODE: | |
MBP | Morphologie im Punktat | - | MATERIAL: Punktat, METHODE: Mikroskopie | |||
MCA | MCA | U/ml | 0.00 | - | 11.00 | MATERIAL: Serum/Vollblut, METHODE: EIA |
MCH | MCH | pg | 27.00 | - | 32.00 | MATERIAL: EDTA-Blut |
MCHC | MCHC | % | 29.5 | - | 36.0 | MATERIAL: EDTA-Blut |
MCV | MCV | fl | 77.00 | - | 96.00 | MATERIAL: EDTA-Blut |
MCVAK | Mut.citrull. Vimentin-AK | U/ml | 0.00 | - | 20.00 | MATERIAL: Serum; Methode: EIA |
MDA | Malondialdehyd | umol/l | 0.000 | - | 0.700 | MATERIAL: EDTA, METHODE: HPLC |
MELAT | Melatonin | pg/ml | 3.80 | - | 80.40 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
MELATH | Melatoninsulfat i.H. | ug/24h | 7.50 | - | 58.10 | MATERIAL: 24h-Sammelharn, Methode: EIA |
Melperon | Melperon | ng/ml | 30.0 | - | 100.0 | MATERIAL: Serum/Vollblut, METHODE: HPLC |
MENG | Meningokokken AK IgG | Titer | 100.0 | - | 1000.0 | MATERIAL: Serum/Vollblut, METHODE: IIF |
MENM | Meningokokken AK IgM | Titer | 50.0 | - | 1000.0 | MATERIAL: Serum/Vollblut, METHODE: IIF |
MESCH | Mescalin i.H. | ug/l | < | 6.00 | MATERIAL: Serum, METHODE: LC-MS | |
META | Metamyelozyten | % | 0.00 | - | 1.00 | MATERIAL: EDTA, |
METAMIZOL | Metamizol | - | MATERIAL: Serum, Methode: LC-MS | |||
METAMPH | Metamphetamine (U) | ng/ml | 0.0 | - | 1000.0 | MATERIAL: Spontanharn, METHODE: EMIT |
METBAL | metabolic balance | - | ||||
METH | Methadon (U) | ng/ml | 0.0 | - | 300.0 | MATERIAL: Spontanharn, METHODE: EMIT |
METHB | Methämoglobin | % | 0.00 | - | 1.00 | MATERIAL: EDTA, METHODE: Spektralphotometrie |
METHECGOS | Methylecgonin (S) | ug/l | < | 2.0 | MATERIAL: Serum, METHODE: FPIA | |
METHISTHKR | Methylhistamin /g Krea i.H. | ug/g Krea | 34.0 | - | 177.0 | MATERIAL: Spontanharn METHODE: LC-MS |
METHPROG | Methadonprogramm | - | ||||
METS | Methadon (S) | ng/ml | - | MATERIAL: Serum/Vollblut; METHODE: FPIA | ||
MG | Magnesium | mmol/l | 0.600 | - | 1.000 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
MGH | Magnesium i.24h H. | mmol/24h | 3.00 | - | 5.00 | MATERIAL: 24h-Sammelharn, METHODE: photometrisch |
MGKZ | Megakaryozyten | % | - | MATERIAL: EDTA, | ||
MGU | Magnesium i.Harn | mmol/l | - | MATERIAL: 24h-Sammelharn, METHODE: photometrisch | ||
MGV | Magnesium im Vollblut (EDTA) | mmol/Ery | 1.650 | - | 2.650 | MATERIAL: EDTA, METHODE: AAS |
MHSOCR_AM | MHS/oCresol Paket | - | MATERIAL: Spontanharn, METHODE: HPLC | |||
MHSU | Methylhippursäure i.H. | g/l | 0.0000 | - | 1.5000 | MATERIAL: Spontanharn, METHODE: HPLC |
MIA | Melanoma Inhib. Activator | pg/ml | < | 1622.0 | MATERIAL: Serum, METHODE: ELISA | |
MIANSERIN | Mianserin | ng/ml | 15.00 | - | 70.00 | MATERIAL: Serum/Vollblut METHODE: LC-MS |
MIKACIN | Amikacin | mg/l | - | MATERIAL: Serum; METHODE: KIMS | ||
MILNACIP | Milnacipran | ng/ml | 100.00 | - | 150.00 | MATERIAL: Serum/Vollblut METHODE: HPLC |
MINERALSTV | Mineralstoffanalyse Vollblut | - | MATERIAL: EDTA + Heparin, METHODE: GC-MS, AAS | |||
MIRTA | Mirtazapin | ng/ml | 30.00 | - | 80.00 | MATERIAL: Serum; Methode: HPLC |
MKNP | Kristallnachweis im Punktat | - | MATERIAL: Punktat, METHODE: Mikroskopie | |||
MKP1 | MKP1-Untersuchung | - | MATERIAL: EDTA-Blut+Vollblut | |||
MKP2 | MKP2-Untersuchung | - | MATERIAL: EDTA-Blut+Vollblut | |||
MMRIMPF | Masern Mumps Röteln Immunstaten | - | MATERIAL: Serum/Vollblut | |||
MMS | Methylmalonsäure im Serum | ug/l | 0.00 | - | 32.00 | MATERIAL: Serum/Plasma METHODE: LCMS |
MMSU | Methylmalonsäure /g Krea i.H. | mg/g Kreat | < | 3.760 | MATERIAL: Harn, METHODE: LC-MS/MS | |
MN | Mangan im Serum | ug/l | 0.30 | - | 1.30 | MATERIAL: Serum/Vollblut, METHODE:AAS |
MNNH | Metanephrin i.24h H. | ug/24h | 0.00 | - | 374.70 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
MNNS | Metanephrin (P) | ng/l | < | 100.0 | MATERIAL: 5ml EDTA-Plasma; METHODE: LC-MS/MS | |
MNU | Mangan i.H. | ug/l | 1.250 | - | 2.250 | MATERIAL: Spontanharn; Methode: photom. |
MNV | Mangan im Vollblut (EDTA) | ug/l | 6.000 | - | 11.000 | MATERIAL: EDTA, METHODE: AAS |
MO | Molybdän im Serum | ug/l | < | 1.000 | MATERIAL: Serum/Vollblut; METHODE: ICP-MS | |
MOCLOBEMID | Moclobemid | µg/l | 300.0 | - | 1000.0 | MATERIAL: Serum, Methode: LC-MS |
MOGG | Myelin-Oligodend.-Glykoprotein | Titer | - | MATERIAL: Serum, METHODE: IFT | ||
MONO | Monozyten | % | 2.00 | - | 10.00 | MATERIAL: EDTA, |
MONOA | Monozyten (abs.) | /µl | 0.0 | - | 800.0 | |
MONOP | Monozyten | % | - | MATERIAL: Punktat | ||
MOV | Molybdän im Vollblut (EDTA) | ug/l | 0.20 | - | 1.30 | MATERIAL: EDTA, METHODE: ICP-MS |
MOXIFLOX | Moxifloxacin | mg/l | - | MATERIAL: Serum; METHODE: LC-MS | ||
MPA | Mycophenolsäure (MPA) | mg/l | 1.00 | - | 4.00 | MATERIAL: EDTA+Serum Methode: HPLC |
MPHH | Methylphenidat i.H. | ug/l | < | 6.00 | MATERIAL: Spontanharn, METHODE: LC-MS | |
MPHS | Methylphenidat (Ritalin) | ng/ml | 12.00 | - | 79.00 | MATERIAL: Serum, METHODE: LC-MS |
MPL_MUT | MPL W515L/K Mutationsnachweis | - | MATERIAL: EDTA 5ml; Methode: PCR | |||
MPV | Mittl.Thrombozyten Vol. (MPV) | fl | 5.90 | - | 12.00 | MATERIAL: EDTA, |
MQUALONH | Methaqualonsäure i.H. | ug/l | < | 6.00 | MATERIAL: Spontanharn, METHODE: LC-MS | |
MRH | Mittleres Retikulozyten Hb. | pg | 28.00 | - | 35.00 | MATERIAL: EDTA, |
MRSA | Methicillin res.Staph.aureus | - | MATERIAL: Abstrich; Methode: Kultur | |||
MSA | TPO (Thyroid-Peroxidase AK) | U/ml | 0.000 | - | 34.000 | MATERIAL: Serum/Vollblut, METHODE: LIA |
MSG | Masern IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | |||
MSGQUANT | Masern IgG Impftiter | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | |||
MSKREAU | Mandelsäure /g Krea i.H. | mg/g Krea | - | MATERIAL: Spontanharn,Methode: HPLC | ||
MSM | Masern IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
MSPCR | Masernvirus RNA (PCR) | - | MATERIAL: Serum, Na/RA-Abstrich METHODE: PCR | |||
MSPCRU | Masernvirus (RNA) PCR i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
MSU | Mandelsäure i.H. | mg/l | - | MATERIAL: Spontanharn, METHODE: HPLC | ||
MTHFR | Homocysteinämie Gentest | - | MATERIAL: EDTA, Methode: Gentest | |||
MTX | Methotrexat | umol/l | - | MATERIAL: Serum/Vollblut od. Heparin; METHODE: CMIA | ||
MUCON | Muconsäure i.H. | mg/l | 0.00 | - | 1.60 | MATERIAL: Spontanharn, METHODE: HPLC |
MUMPSG | Mumps IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
MUMPSM | Mumps IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
MUMPSQUANT | Mumps IgG Impftiter | U/ml | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | ||
MUSKAK | Musk.sp.Rezept.Tyrosin-Kinase | U/ml | < | 0.40 | MATERIAL: Serum; Methode: ELISA | |
MX1 | MX1 Schimmelpilze | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
MYALGIE | BLOCK MYALGIE | - | ||||
MYGENPCR | Mycopl. genitalium DNA (PCR) | - | MATERIAL: Abstrich; METHODE: PCR | |||
MYGENPCRU | Mycopl. genitalium (PCR) i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
MYK | Antimykogramm | - | MATERIAL: Epithelien/Abstrich | |||
MYKULT | Mycoplasmen Kultur | 0.0 | - | 20.0 | MATERIAL: Serum/Vollblut, METHODE: | |
MYO | Myoglobin | ug/l | 19.0 | - | 72.0 | MATERIAL: Serum/Vollblut, METHODE: ECLIA |
MYOCARD | BLOCK MYOCARDITIS | - | ||||
MYOGBLOT | Myositis IgG Lineblot | - | MATERIAL: Serum/Vollblut, METHODE: IBLOT | |||
MYOH | Myoglobin i.H. | ug/l | 0.00 | - | 0.10 | MATERIAL: Spontanharn, METHODE: turbidimetrisch |
MYOSITISAK | Myositis Ak Screening | - | MATERIAL: Serum/Vollblut, METHODE: IBLOT | |||
MYPNEUG | Mycoplasma pneum. IgG | U/ml | 0.00 | - | 25.00 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
MYPNEUM | Mycoplasma pneum. IgM | U/ml | 0.00 | - | 25.00 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
MYPNEUPCR | Mycopl.pneumoniae DNA (PCR) | - | MATERIAL: Abstrich/Harn; METHODE: PCR | |||
MYTUBPCR | Mycobact.tuberculosis DNA (PCR) | - | MATERIAL: Sputum, METHODE: PCR | |||
NA | Natrium | mmol/l | - | MATERIAL: Serum/Vollblut, METHODE: ISE | ||
NADRH | Noradrenalin i.24h H. | ug/24h | 23.00 | - | 105.00 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
NADRS | Noradrenalin (P) | pg/ml | 165.0 | - | 460.0 | MATERIAL: EDTA Plasma, METHODE: HPLC |
NAG | N-Acetyl-Glucosaminidase i.H. | U/l | 0.30 | - | 12.00 | MATERIAL: Spontanharn, METHODE: photometrisch |
NAH | Natrium i.24h H. | mmol/24h | 20.00 | - | 220.00 | MATERIAL: 24h-Sammelharn, METHODE: ISE |
NDNA | N-DNA-Antikörper | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
NEO | Neopterin im Serum | nmol/l | 0.00 | - | 10.40 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
NEOH | Neopterin /mol Krea i.H. | umol/mol Krea | 0.0 | - | 405.0 | MATERIAL: Spontanharn, METHODE: ELISA |
NEOU | Neopterin i.Harn | nmol/l | - | MATERIAL: Sammelharn, METHODE: ELISA | ||
NETIL | Netilmicin | ug/ml | 0.50 | - | 10.00 | MATERIAL: Serum/Vollblut |
NI | Nickel im Serum | ug/l | 0.000 | - | 1.000 | MATERIAL: Serum/Vollblut, METHODE: AAS |
NIH | Nickel i.24h H. | ug/24h | 0.00 | - | 7.50 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
NITRIT | Nitrit i.H. | - | MATERIAL: Spontanharn, METHODE: STIX | |||
NIU | Nickel i.Harn | ug/l | 0.00 | - | 3.00 | MATERIAL: Spontanharn, METHODE: AAS |
NIV | Nickel im Vollblut (EDTA) | ug/l | 0.00 | - | 3.30 | MATERIAL: EDTA, METHODE: ICP-A |
NKABS | Natural Killer Zellen absolut | /mm3 | 90.0 | - | 590.0 | MATERIAL: EDTA-Blut, METHODE: flow cytometrie |
NKREL | Natural Killerzellen relativ | % | 6.0 | - | 29.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |
NNRAK | Nebennierenrinden AK | - | MATERIAL: Serum; METHODE: IFT | |||
NORMNNH | Normetanephrin i.24h H. | ug/24h | 0.00 | - | 824.40 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
NOROPCR | Norovirus (RNA) PCR | - | MATERIAL: Stuhl, METHODE: PCR | |||
NRNP | RNP/Sm | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
NSE | NSE | ug/l | 0.00 | - | 18.30 | MATERIAL: Serum/Vollblut, METHODE: EIA |
NTX | Kollagen Telopeptid (NTX) | nMBCE/l | - | MATERIAL:Serum; METHODE:ELISA | ||
NTYR | Nitrotyrosin | µg/l | < | 1.0000 | MATERIAL: EDTA-Plasma Methode: ELISA | |
O1 | O1 Baumwollfaser | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
O203 | O203 Tetramin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
O214 | O214 CCD (Carbohyd.Determ.) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
O215 | O215 Alpha-1,3-Gal | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
O3_ALA | a-Linolensäure (ALA) | mg/l | 13.900 | - | 59.200 | MATERIAL: Serum/Vollblut |
O3_DHA | Docosahexaensäure (DHA) | mg/l | 67.200 | - | 141.000 | MATERIAL: Serum/Vollblut |
O3_EPA | Eicosapentaensäure (EPA) | mg/l | 25.670 | - | 61.560 | MATERIAL: Serum/Vollblut |
O6_AA | Arachidonsäure (AA) | mg/l | 172.000 | - | 335.000 | MATERIAL: Serum/Vollblut |
O6_BGLA | Dihomo-Gamma-Linolsäure (BGLA) | mg/l | 34.200 | - | 82.600 | MATERIAL: Serum/Vollblut |
O6_GLA | Gamma-Linolensäure (GLA) | mg/l | 7.200 | - | 27.850 | MATERIAL: Serum/Vollblut |
O6_LA | Linolsäure (LA) | mg/l | 945.000 | - | 1516.000 | MATERIAL: Serum/Vollblut |
O70 | O70 Sperma/Ejakulat | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
OCRESOL | Ortho-Cresol | mg/l | 0.00 | - | 0.80 | MATERIAL: Spontanharn, METHODE: HPLC |
OESTRA | Oestradiol (E2) | ng/l | - | MATERIAL: Serum/Vollblut, METHODE: LIA | ||
OESTRABV | Oestradiol bioverfügbar | pg/ml | - | MATERIAL: Serum/Vollblut, METHODE: | ||
OESTRI | Oestriol (E3) | ug/l | - | MATERIAL: Serum/Vollblut, METHODE: FPIA | ||
OESTRON | Oestron (E1) | pg/ml | 0.00 | - | 320.00 | MATERIAL: Serum/Vollblut, METHODE: RIA |
OLAN | Olanzapin | µg/l | 20.000 | - | 80.000 | MATERIAL: Serum/Vollblut, METHODE: HPLC |
OMEGAFSR | Omega 3/6 Fettsren. + Quotient | - | MATERIAL: min. 4ml Serum | |||
OMEGAFSREM | Omega 3/6 Fettsren.i.Erymembran | - | MATERIAL: min. 4ml EDTA | |||
OMEGAFSRV | Omega 3/6 Fettsren. im Vollblut | - | MATERIAL: min. 4ml EDTA | |||
OMEGAQ | Omega 3/6 Quotient EPA/AA | % | > | 15.00 | MATERIAL: Serum/Vollblut, METHODE: GC/MS | |
OPIH | Opiate (U) | ng/ml | 0.0 | - | 300.0 | MATERIAL: Spontanharn, METHODE: EMIT |
OPIPRAMOL | Opipramol | ug/l | 50.0 | - | 500.0 | MATERIAL: Serum; METHODE: HPLC |
OPIS | Opiate (S) | ug/l | < | 10.000 | MATERIAL: Serum/Vollblut; METHODE: FPIA | |
ORGSRNU | Organische Säuren i.H. | - | Material: Spontanharn 5ml | |||
OSMO | Osmolalität im Serum | mosmol/kg | 280.0 | - | 295.0 | MATERIAL: Serum/Vollblut |
OSMOST | Osmolalität i.St. | mosm/kg | 280.0 | - | 390.0 | MATERIAL: Stuhl |
OSMO-U | Osmolalität i.H. | mosmol/kg | 50.0 | - | 1200.0 | MATERIAL: Spontanharn |
OSTEO | Osteocalcin | ng/ml | 4.60 | - | 65.40 | MATERIAL: Serum/Vollblut, METHODE: LIA |
OSTEOPROT | Osteoprotegerin | pmol/l | 0.860 | - | 2.840 | MATERIAL: Serum/Vollblut, METHODE: |
OVARAK | Ovar Antikörper | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
OXALAH | Oxalsäure i.24h H. | mg/24h | 0.00 | - | 43.90 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: |
OXALAU | Oxalsäure i.24h H. | mg/l | - | MATERIAL: 24h-Sammelharn angesäuert, METHODE: | ||
OXAZEPAM | Oxazepam | ug/l | 200.00 | - | 1500.00 | MATERIAL: Serum, METHODE: LC-MS |
OXCARBA | Oxcarbazepin (10-OH-Metab.) | ug/ml | 10.00 | - | 30.00 | MATERIAL: Vollblut/Serum |
OXYCODON | Oxycodon | ug/l | 5.000 | - | 50.000 | MATERIAL: Serum, Methode: LC-MS |
P | Phosphor | mmol/l | 0.740 | - | 1.520 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
P1 | P1 Ascaris | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
P53 | P53-AK | U/ml | < | 120.0 | MATERIAL: Serum/Vollblut | |
PAN_GASTRO | Gastrointestinales PCR Panel | - | MATERIAL: Stuhl, METHODE: PCR | |||
PAN_RESPI | Respiratorisches PCR Panel | - | MATERIAL: Abstrich; METHODE: PCR | |||
PAN_VESIC | Vesiculäres PCR Panel | - | MATERIAL: Abstrich; METHODE: PCR | |||
PANCA | ANCA-p (anti-MPO) | U/ml | 0.00 | - | 20.00 | MATERIAL: Serum/Vollblut, METHODE: CLIA |
PAP | PAP Abstrich | - | MATERIAL: Abstrich; Methode: cytologisch | |||
PAPP-A | PAPP-A | - | MATERIAL: Serum/Vollblut, METHODE: TRACE | |||
PARA1 | Parainfluenza 1 | Titer | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE: KBR |
PARA2 | Parainfluenza 2 | Titer | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE: KBR |
PARA3 | Parainfluenza 3 | Titer | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE: KBR |
PARAAG | Parainfluenza Antigennachweis | - | MATERIAL: Nasensekret | |||
PARACET | Paracetamol | mg/l | 5.00 | - | 25.00 | MATERIAL: Serum/Vollblut METHODE: GC-MS |
PARAT | Parathormon | ng/l | 10.0 | - | 70.0 | MATERIAL: Serum/Vollblut, METHODE: LIA |
PARATRELP | Parathormon related Protein | pmol/l | 0.00 | - | 1.40 | MATERIAL: EDTA-Plasma gefroren, METHODE: RIA |
PARIETA | Parietalzell-AK | U/ml | 0.00 | - | 9.90 | MATERIAL: Serum/Vollblut METHODE: ELISA |
PAROTISAK | Speicheldrüsengangepithel AK | - | MATERIAL: Serum; METHODE: IFT | |||
PAROTITIS | BLOCK PAROTITIS | - | ||||
PAROXETIN | Paroxetin | ng/ml | 20.0 | - | 65.0 | MATERIAL: Serum/Vollblut, METHODE: LC-MS/MS |
PARVOAVID | Parvovirus B19 Avidität | - | MATERIAL: Serum/Vollblut | |||
PARVOG | Parvovirus B19 IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
PARVOM | Parvovirus B19 IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
PARVOPCR | Parvovirus B19 DNA (PCR) | - | MATERIAL: Serum/Sputum/Punktat, METHODE: PCR | |||
PARVOQUANT | Parvovirus B19 IgG Titer | U/ml | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | ||
PBGH | Porphobilinogen i.24h H. | mg/24h | 0.100 | - | 1.700 | MATERIAL: 24h-Sammelharn, METHODE: Säulentrennung/photom. |
PBGU | Porphobilinogen i.H. | mg/l | - | MATERIAL: Spontanharn,24h-Sammelharn METHODE:Säulentrennung/photom. | ||
PCLEAR | Phosphat - Clearance | ml/min | 5.40 | - | 16.20 | MATERIAL: Serum/Vollblut+24h-Sammelharn |
PCNA | PCNA | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
PCP | Pentachlorphenol | ug/l | < | 12.000 | MATERIAL: Serum (5 ml), METHODE: GC-MS | |
PD | Palladium im Serum | ug/l | 0.00 | - | 0.20 | MATERIAL: Serum/Vollblut, METHODE: AAS |
PEMPHAK | Pemphigus-Ak | - | ||||
PEPSINOGEN | Pepsinogen | ug/l | - | MATERIAL: Serum, METHODE: EIA | ||
PERAMP | Perampanel | ug/l | 180.00 | - | 980.00 | MATERIAL: Serum, METHODE: LC-MS |
PERTA | Pertussis IgA | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
PERTG | Pertussis IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
PERTGQUANT | Pertussis IgG Impftiter | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
PERTM | Pertussis IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
PERTPCR | B.pertussis DNA (PCR) | - | MATERIAL: Abstrich; METHODE: PCR | |||
PF4AK | Heparin/PF4 AK (HIT) | - | MATERIAL: Serum Methode:ELIA | |||
PGAKREAU | Phenylglyoxylsäure /g Krea i.H. | mg/g Krea | - | MATERIAL: Spontanharn,Methode: HPLC | ||
PGAU | Phenylglyoxylsäure i.H. | mg/l | - | MATERIAL: Spontanharn, METHODE: HPLC | ||
PH | Phosphor i.24h H. | mmol/24h | 13.000 | - | 42.000 | MATERIAL: 24h-Sammelharn, METHODE: photometrisch |
PHENCYH | Phencyclidin (U) | ng/ml | 0.0 | - | 25.0 | MATERIAL: Spontanharn, METHODE: FPIA |
PHENCYS | Phencyclidin (S) | ng/ml | 0.0 | - | 20.0 | MATERIAL: Serum, METHODE: FPIA |
PHENO | Phenobarbital | ug/ml | 14.90 | - | 40.10 | MATERIAL: Serum/Vollblut, METHODE: FPIA |
PHENY | Phenytoin | ug/ml | 10.00 | - | 20.00 | MATERIAL: Serum/Vollblut, METHODE: FPIA |
PHKAT | PH-Wert (Sammelharn) | 2.0 | - | 3.0 | MATERIAL: 24h-Sammelharn angesäuert, METHODE:ph-metr. | |
PHWH | PH-Wert (U) | 5.00 | - | 7.00 | MATERIAL: Spontanharn, METHODE: STIX | |
PHYTANSRE | Phytansäure | mg/l | < | 5.00 | MATERIAL: Serum Methode: GC-MS | |
PHYTSRE | Phytansäure | umol/l | < | 10.00 | MATERIAL: Serum Methode: GC-MS | |
PILZ | Pilze Kultur | - | MATERIAL: Epithel, METHODE: Kultur | |||
PINP | PINP Prokollagen I N Propeptid | ug/l | - | MATERIAL: Serum METHODE: ECLIA | ||
PLA2RAK | Phospholipase-A2-Rezeptor AK | RE/ml | < | 14.0 | MATERIAL: Serum; Methode: ELISA | |
PLAP | PLAP (ELISA) | mU/l | 0.0 | - | 100.0 | MATERIAL: Serum/Vollblut, METHODE: EIA |
PLASsppAG | Plasmodium spp AG (ICT) | - | MATERIAL: Serum/Vollblut, METHODE: ICT | |||
PNEUMONIE | BLOCK PNEUMONIE | - | ||||
PNEUPCR | Pneumokokken PCR | - | MATERIAL: Abstrich ; METHODE: PCR | |||
PNEUQUANT | Pneumokokken IgG Impftiter | mg/l | 0.00 | - | 3.20 | MATERIAL: Serum/Vollblut, METHODE: EIA |
POLIONEU1 | Polio Typ1 Impftiter | Titer | - | MATERIAL: Serum | ||
POLYAR | Waaler-Rose-Test | - | MATERIAL: Serum/Vollblut, METHODE: Agglutination | |||
PORPHDIFFH | Porphyrindifferenzierung | - | ||||
PORPHGES | Porphyrine i. Serum | ug/dl | < | 2.000 | MATERIAL: Serum, METHODE: HPLC | |
PORPHGESH | Gesamtporphyrine (24h H.) | ug/24h | < | 100.000 | MATERIAL: 24h-Sammelharn, METHODE: Säulentrennung/photom. | |
PRAEAK | Präzipitierende IgG-Antikörper | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
PRAEALB | Präalbumin | g/l | 0.200 | - | 0.400 | MATERIAL: Serum/Vollblut METHODE: Nephelometrisch |
PRÄZFARMER | Farmerlunge Präz.IgG-AK | - | MATERIAL: Serum, METHODE: ELISA | |||
PRÄZVOGEL | Vogelhalterlunge Präz.IgG-AK | - | MATERIAL: Serum, METHODE: ELISA | |||
PREG | Pregnandiol i.24h H. | mg/24h | 0.00 | - | 9.50 | MATERIAL: 24h-Sammelharn angesäuert |
PREGABA | Pregabalin | mg/l | 2.00 | - | 5.00 | MATERIAL: Serum/Vollblut METHODE: LC-MS/MS |
PREGSULF | Pregnenolonsulfat | ug/l | 27.00 | - | 80.00 | MATERIAL: Serum/Vollblut, |
PRIM | Primidon | mg/l | 5.00 | - | 10.00 | MATERIAL: Serum/Vollblut, METHODE: FPIA |
PRISTANSRE | Pristansäure | umol/l | < | 3.000 | MATERIAL: Serum Methode: GC-MS | |
PRNT | PRNT auf SARS-CoV-2 | - | MATERIAL: Serum/Vollblut, METHODE: Neutralisationstest | |||
PROBNP | NT-proBNP | pg/ml | 0.000 | - | 486.000 | MATERIAL: Serum/Vollblut |
PROCALC | Procalcitonin | ug/l | 0.000 | - | 0.500 | MATERIAL: Serum; Methode: LIA |
PROG | Progesteron | ug/l | 0.000 | - | 14.500 | MATERIAL: Serum/Vollblut, METHODE: CMIA |
PROINS | Proinsulin (intaktes) | pmol/l | 0.000 | - | 10.000 | MATERIAL: Serum/Vollblut, METHODE: |
PROL | Prolactin | ng/ml | - | MATERIAL: Serum/Vollblut, METHODE: CMIA | ||
PROLPEG | Prolactin nach PEG-Fällung | ng/ml | - | MATERIAL: Serum/Vollblut, METHODE: CMIA | ||
PROPAFENON | Propafenon | mg/l | 0.400 | - | 1.600 | MATERIAL: Serum, METHODE: LC-MS |
PROPOXYU | Propoxyphen i.H. | ug/l | 0.0 | - | 50.0 | MATERIAL: Spontanharn; Methode: LC-MS |
PROTC | Protein C-Aktivität (chromogen) | % | 70.0 | - | 140.0 | MATERIAL: Citrat, METHODE: ELFA |
PROTH | Protein i.24h H. | g/24h | 0.020 | - | 0.150 | MATERIAL: 24h-Sammelharn, METHODE: turbidimetrisch |
PROTHIPEN | Prothipendyl | ug/l | 5.00 | - | 20.00 | MATERIAL: Serum; METHODE: LC-MS |
PROTSF | Protein S (frei) | % | 60.10 | - | 139.00 | MATERIAL: Citrat, METHODE: chromogenes Substrat |
PROTUQ | Protein Kreatinin Ratio i.H. | mg/g | 0.00 | - | 100.00 | |
PSA | PSA Screening | ng/ml | 0.000 | - | 4.000 | MATERIAL: Serum/Vollblut, METHODE: CMIA |
PSAFTU | PSA-frei (Tumormarker) | % | > | 18.00 | MATERIAL: Serum/Vollblut, METHODE: CMIA | |
PSILOCYBH | Psilocybin (U) | ng/ml | 0.0 | - | 10.0 | MATERIAL: Spontanharn (10ml), METHODE: CEDIA |
PT | PT (Quick) | % | 70.0 | - | 120.0 | MATERIAL: Citrat, METHODE: Clotting |
PTAK | Anti Prothrombin Ak Scr. | U/ml | 0.00 | - | 20.00 | MATERIAL: Serum/Vollblut METHODE: ELISA |
PTMUT | PT-Mutation 20210A | - | MATERIAL: EDTA; Methode: Gentest | |||
PTT | PTT | sec | 23.0 | - | 40.0 | MATERIAL: Citrat, METHODE: Clotting |
PTTLA | aPTT (Lupus-Ak-sensitiv) | sec | 26.0 | - | 41.0 | MATERIAL: Citrat, |
PYRUVAT | Pyruvat | umol/l | 39.00 | - | 82.00 | MATERIAL: Fluorid-Blut, METHODE: photometrisch |
QFKBR | Q-Fieber KBR | Titer | - | MATERIAL: Serum/Vollblut, METHODE: KBR | ||
QFT | Quantiferon Test (IGRA) | - | MATERIAL: Heparin-Vollblut 8ml, METHODE: CLIA | |||
QUECK_SP | Quecksilber im Speichel | ug/l | 0.00 | - | 2.70 | MATERIAL: Sputum, METHODE: AAS |
QUECK_SP2 | Quecksilber nach Provokation | ug/l | 0.00 | - | 2.70 | MATERIAL: Sputum, METHODE: AAS |
QUECKH | Quecksilber i.24h H. | ug/24h | 0.00 | - | 1.50 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
QUECKU | Quecksilber i.Harn | ug/l | 0.00 | - | 1.00 | MATERIAL: Spontanharn, METHODE: AAS |
QUECKUKR | Quecksilber /g Krea i.H. | ug/g Krea | - | MATERIAL: Spontanharn, METHODE: AAS | ||
QUECKV | Quecksilber im Vollblut (EDTA) | ug/l | 0.00 | - | 2.00 | MATERIAL: EDTA-Blut, METHODE: AAS |
QUET | Quetiapin | ug/l | 100.00 | - | 500.00 | MATERIAL: Serum/Vollblut, METHODE: HPLC |
RANTES | RANTES | ng/ml | < | 30.00 | MATERIAL: Serum, METHODE: ELISA | |
RBB | Rotes Blutbild | - | MATERIAL: EDTA | |||
RBG | Rubeolen IgG | IU/ml | - | MATERIAL: Serum/Vollblut, METHODE: ECLIA | ||
RBGAVID | Rubeolen IgG Avidität | - | MATERIAL: Serum/Vollblut | |||
RBGQUANT | Rubeolen IgG Impftiter | IU/ml | - | MATERIAL: Serum/Vollblut, METHODE: ECLIA | ||
RBM | Rubeolen IgM | - | MATERIAL: Serum/Vollblut, METHODE: ECLIA | |||
RDW | Erythrozytenverteilungsbreite | % | 11.50 | - | 14.50 | MATERIAL: EDTA-Blut |
REBOXETIN | Reboxetin | ng/ml | 60.00 | - | 350.00 | MATERIAL: Serum/Vollblut METHODE: |
RENIN | Renin direkt | mIU/l | 2.800 | - | 46.100 | MATERIAL: EDTA-Plasma gefroren, METHODE: LIA |
RET | Retikulozyten | %o | 5.0 | - | 22.0 | MATERIAL: EDTA-Blut |
RETAK | Retikulin Antikörper | - | MATERIAL: Serum/Vollblut | |||
RF269 | RF269 Rucola | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
RFA | Rheumafaktor IgA-Typ | RE/ml | < | 20.000 | MATERIAL: Serum/Vollblut METHODE: EILSA | |
RFG | Rheumafaktor IgG-Typ | RE/ml | < | 20.000 | MATERIAL: Serum/Vollblut METHODE: ELISA | |
RFM | Rheumafaktor IgM-Typ | RE/ml | < | 20.000 | MATERIAL: Serum/Vollblut METHODE: EILSA | |
RH | Rhesusfaktoren | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
RIB-P | Ribosomales Protein P | - | MATERIAL: Serum/Vollblut, METHODE:Immunoblot | |||
RICKRICKG | Rickettsia rickettsii IgG | Titer | 0.0 | - | 64.0 | MATERIAL: Serum/Vollblut, METHODE: IFT |
RICKRICKM | Rickettsia rickettsii IgM | Titer | 0.0 | - | 64.0 | MATERIAL: Serum/Vollblut, METHODE: IFT |
RICKsppG | Rickettsia spp. IgG | Ratio | 0.00 | - | 1.10 | MATERIAL: Serum, METHODE: ELISA |
RICKsppM | Rickettsia spp. IgM | Ratio | 0.00 | - | 1.20 | MATERIAL: Serum, METHODE: ELISA |
RIFAMPI | Rifampicin | mg/l | 8.000 | - | 24.000 | MATERIAL: Serum; METHODE: LC-MS |
RISP | Risperidon | ug/l | - | MATERIAL: Serum; Methode: HPLC | ||
RISP_GES | Risperidon + 9-OH-Risperidon | ug/l | 20.00 | - | 60.00 | |
RITH | Ritalinsäure i.H. | ug/l | < | 6.00 | MATERIAL: Spontanharn, METHODE: LC-MS | |
RO52 | Ro (SS-A 52) | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
RO60 | Ro (SS-A 60) | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
ROMA | Roma-Index | - | MATERIAL: Serum/Vollblut | |||
ROMAPOST | ROMA postmenopausal | % | - | |||
ROMAPRE | ROMA prämenopausal | % | - | |||
ROTA | Rotaviren | - | MATERIAL: Serum/Vollblut | |||
ROTAG | Rotavirus Antigen | - | MATERIAL: Sekret | |||
ROTAPCR | Rotavirus (RNA) PCR | - | MATERIAL: Stuhl, METHODE: PCR | |||
RSAG | RSV Antigen | - | MATERIAL: Nasensekret, METHODE: PCR | |||
RSVA | RSV IgA-Ak | RATIO | 0.000 | - | 1.100 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
RSVG | RSV IgG-Ak | U/ml | 0.00 | - | 22.00 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
RSVKBR | Resp. Syncytialvirus KBR | Titer | < | 40.0 | MATERIAL: Serum, METHODE: KBR | |
RSVM | RSV IgM-Ak | RATIO | 0.000 | - | 0.800 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
RSVPCR | RSV RT-PCR-Nachweis | - | MATERIAL: Abstrich, METHODE: RT-PCR | |||
RT3 | T3 Revers | ng/ml | 0.120 | - | 0.350 | MATERIAL: Serum/Vollblut, METHODE: EIA |
RUFINAMID | Rufinamid | ug/ml | 1.00 | - | 10.00 | MATERIAL: Serum/Vollblut METHODE: |
S100 | S100 | ug/l | 0.0000 | - | 0.1600 | MATERIAL: Serum/Vollblut; METHODE: Chemielumiszenzassay |
SALICYLATE | Salicylate | mg/l | 20.00 | - | 200.00 | MATERIAL: Serum, METHODE: Photometrisch |
SALM | Salmonella Gruppe | - | MATERIAL: Serum/Vollblut | |||
SALMA | Salmonella IgA | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
SALMKULT | Salmonellen Kultur | - | MATERIAL: Stuhl, METHODE: Kultur | |||
SALMSUCH | Salmonella IgA/IgM/IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
SAPOPCR | Sapovirus (RNA) PCR | - | MATERIAL: Stuhl, METHODE: PCR | |||
SB | Antimon im Serum | ug/l | < | 0.20 | MATERIAL: Serum, METHODE: AAS | |
SBU | Antimon i.H. | ug/l | < | 0.20 | MATERIAL: Spontanharn, METHODE: AAS | |
SCAA | Saccharomyces cerevisiae IgA | RE/ml | 0.00 | - | 20.00 | MATERIAL; Serum/Vollblut, METHODE: Immunoblot |
SCAG | Saccharomyces cerevisiae IgG | RE/ml | 0.00 | - | 20.00 | MATERIAL; Serum/Vollblut, METHODE: Immunoblot |
SCC | SCC | ng/ml | 0.00 | - | 2.30 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
SCHISTOG | Schistosomen-IgG AK | Units | 0.00 | - | 8.40 | MATERIAL: Serum/Vollblut, METHODE: |
SCHWEFEL | Schwefel | mg/l | 994.0 | - | 1420.0 | MATERIAL: Serum, METHODE: ICP-MS |
SCL70 | Scl-70 | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
SCT | Silica-Clotting-Zeit (SCT) | Ratio | 0.000 | - | 1.100 | MATERIAL: Citrat, |
SE | Selen im Serum | ug/dl | 3.200 | - | 12.000 | MATERIAL: Serum/Vollblut, METHODE: AAS |
SED | Harnsediment | - | MATERIAL: Spontanharn, METHODE: Mikroskopie | |||
SEG | Segmentkern. Neutrophile | % | 50.00 | - | 75.00 | MATERIAL: EDTA-Blut |
SEGA | Segmentker. Neutrophile (abs.) | /µl | 1600.0 | - | 7000.0 | |
SEGP | Segmentkern. Neutrophile | % | - | MATERIAL: Punktat | ||
SEROTH | Serotonin i.24h-H. | ug/24h | 27.00 | - | 183.00 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
SEROTS | Serotonin im Serum | ng/ml | 40.0 | - | 200.0 | MATERIAL: Serum/Vollblut; Methode: HPLC |
SERTINDOL | Sertindol | ng/ml | 50.00 | - | 100.00 | MATERIAL: Serum/Vollblut METHODE: LS-MS |
SERTRALIN | Sertralin | ng/ml | 10.0 | - | 150.0 | MATERIAL: Serum/Vollblut, METHODE: LC-MS/MS |
SEV | Selen im Vollblut (EDTA) | ug/l | 60.00 | - | 130.00 | MATERIAL: EDTA, METHODE: AAS |
SEXHORM_M | Sexualhormonstatus Mann | - | MATERIAL: Serum/Vollblut, METHODE: diverse | |||
SEXHORM_W | Sexualhormonstatus Frau | - | MATERIAL: Serum/Vollblut, METHODE: deverse | |||
SFLT1PLGFQ | sFlt1/PlGF-Quotient | - | Negativer prädiktiver Wert (Ausschluß einer Präeklampsie): <38 | |||
SHBG | SHBG | nmol/l | 13.0 | - | 128.0 | MATERIAL: Serum/Vollblut, METHODE: LIA |
SHIG | Shigella Gruppe | - | MATERIAL: Serum/Vollblut | |||
SHIG1 | Shigella dysent.1 Aggl. | Titer | < | 100.0 | MATERIAL: Serum/Vollblut, METHODE: Agglutination | |
SHIG2 | Shigella dysent.2 Aggl. | Titer | < | 100.0 | MATERIAL: Serum/Vollblut, METHODE: Agglutination | |
SHIGA | Shigella flexneri IgA | - | MATERIAL: Serum/Vollblut, METHODE: EIA | |||
SHIGFLEX | Shigella flexneri (WIDAL) | Titer | < | 50.0 | MATERIAL: Serum/Vollblut, METHODE: Agglutination | |
SHIGG | Shigella flexneri IgG | - | MATERIAL: Serum/Vollblut, METHODE: EIA | |||
SHIGKULT | Shigellen Kultur | - | MATERIAL: Stuhl, METHODE: Kultur | |||
SHIGSONN | Shigella sonnei (WIDAL) | Titer | < | 100.0 | MATERIAL: Serum/Vollblut, METHODE: Agglutination | |
SI | Silicium im Serum | ug/l | < | 421.0 | MATERIAL: Serum/Vollblut; METHODE: AAS | |
SIRO | Sirolimus | ug/l | - | MATERIAL: EDTA-Blut, METHODE: LC-MS | ||
SIU | Silicium i.H. | ug/l | 2900.0 | - | 12100.0 | MATERIAL: Spontanharn; METHODE: ICP-MS |
SKELA | Skelettmuskel-AK | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
SLA | SLA (soluble liver antigen) | - | MATERIAL: Serum/Vollblut | |||
SM | Sm | - | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |||
SMA | SMA | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
SN | Zinn | ug/l | 0.00 | - | 2.00 | MATERIAL: Heparinplasma; METHODE: AAS |
SOD | Superoxid-Dismutase 2 (Mn SOD) | U/ gHb | 1100.0 | - | 1600.0 | MATERIAL: Li-Heparinblut od. 2x EDTA-Blut, Methode: |
SPERMIENAK | Spermatozoen-Ak | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
SPICEH | Spice/K2 (synth. Cannab.) (U) | ng/ml | 0.0 | - | 50.0 | MATERIAL: Spontanharn, METHODE: EMIT |
SPUTUM | Sputumkultur | - | MATERIAL: Sputum, METHODE: Kultur | |||
STAB | Stabkernige Neutrophile | % | 0.00 | - | 4.00 | MATERIAL: EDTA, |
STABA | Stabkernige Neutrophile (abs.) | /µl | - | |||
STABP | Stabkernige Neutrophile | % | - | MATERIAL: Punktat | ||
STACHAK | Stachelzelldesm.AK.(IFT) | Titer | < | 10.0 | MATERIAL: Serum/Vollblut, METHODE: IFT | |
STAMOEB | Stuhl auf Amöben | - | MATERIAL: Stuhl, METHODE: mikrosk.Nachw.i.Frischpräp. | |||
STATFEB | BLOCK ST.FEBRILIS | - | ||||
STATH | Harnstatus | - | MATERIAL: Harn, METHODE: STIX | |||
STBL | Stuhl auf Blut | - | MATERIAL: Stuhl, METHODE: diverse | |||
STBLUT | Blut i.St. | - | MATERIAL: Stuhl | |||
STCAND | Stuhl auf Candida | < 10.000 KBE/g | - | MATERIAL: Stuhl, METHODE: Kultur | ||
STD | BLOCK SEX.TRANSM.DISEASES | - | ||||
STEIN | Steinanalyse | - | MATERIAL: Harnstein, METHODE: chemisch | |||
STFLORA | Mikroökologische Stuhlflora | - | MATERIAL: Stuhl, METHODE: Klassische Stuhlanalyse über Anzucht | |||
STKLEB | Stuhl auf Klebsiellen | - | MATERIAL: Stuhl | |||
STMIK_MAX | Mikrobiomanalyse Maxi i.St. | - | MATERIAL: Stuhl | |||
STMIK_MIN | Mikrobiomanalyse Mini i.St. | - | MATERIAL: Stuhl | |||
STPATH | Stuhl auf pathogene Keime | - | MATERIAL: Stuhl, METHODE: Kultur | |||
STPNAGH | Strept.pneumoniae AG i.H. | - | MATERIAL: Spontanharn; Methode: FIA | |||
STRONGAK | Strongyloides sp AK | Units | 0.00 | - | 11.00 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
STUHL | Stuhluntersuchungen | - | MATERIAL: Stuhl, METHODE: diverse | |||
STWE | Wurmeier i.St. | - | MATERIAL: Stuhl, METHODE: Anreicherung n. Telemann | |||
SULFAMETH | Sulfamethoxazol | mg/l | 40.00 | - | 60.00 | MATERIAL: Serum; METHODE: HPLC |
SULPIRID | Sulpirid | ng/ml | 200.00 | - | 1000.00 | MATERIAL: Serum/Vollblut METHODE: LC-MS |
SULT | Sultiam | mg/l | 6.0 | - | 10.0 | MATERIAL: Serum; Methode: EIA |
SUPABS | Suppressorzellen absolut | /mm3 | 190.0 | - | 1140.0 | MATERIAL: EDTA-Blut, METHODE: flow cytometrie |
SUPREL | Suppressorzellen relativ | % | 19.0 | - | 48.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |
SX1 | SX1 Inhalationsallergene | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T1 | T1 Ahorn | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T10 | T10 Walnusspollen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T11 | T11 Platane | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T12 | T12 Salweide | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T14 | T14 Pappel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T15 | T15 Esche | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T16 | T16 Kiefer | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T18 | T18 Eukalyptus | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T2 | T2 Erle | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T201 | T201 Fichte | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T203 | T203 Rosskastanie | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T205 | T205 Holunder | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T206 | T206 Esskastanie | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T208 | T208 Linde | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T214 | T214 Dattelpalme | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T215 | T215 rBet v 1 Birke | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T216 | T216 rBet v 2 Birke | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T220 | T220 rBet v 4 Birke | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T221 | T221 rBet v 2/4 Birke | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T224 | T224 rOle e 1, Olivenbaum | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T23 | T23 Zypresse | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T3 | T3 (Gesamt-Trijodthyronin) | nmol/l | 1.300 | - | 3.100 | MATERIAL: Serum/Vollblut, METHODE: CMIA |
T3B | T3B Birke | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T4H | T4H Hasel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T5 | T5 Buche | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T6 | T6 Sadebaum | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T7 | T7 Eiche | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T8 | T8 Ulme | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
T9 | T9 Olivenpollen | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
TABS | T-Zellen absolut | /mm3 | 690.0 | - | 2540.0 | MATERIAL: EDTA-Blut, METHODE: flow cytometrie |
TACRO | Tacrolimus FK 506 | ug/l | - | MATERIAL: EDTA-Blut, METHODE: LC-MS | ||
TAMOXIFEN | Tamoxifen | ug/l | 100.0 | - | 220.0 | MATERIAL: Serum, METHODE: LC-MS |
TAS | Total antioxidant status | umol/l | - | MATERIAL: Serum/Vollblut, METHODE: photometrisch | ||
TAT | Thrombin-Antithr.III-Komplex | ug/l | 1.00 | - | 4.10 | MATERIAL: Citrat, METHODE: ELISA |
TBCH | Tbc Harnkultur | - | MATERIAL: Spontanharn, METHODE: Kultur | |||
TBCSPUT | TBC - Nachweis im Sputum | - | MATERIAL: Sputum, METHODE: Kultur | |||
TBG | Thyroxin binding Globulin | mg/l | 11.30 | - | 36.30 | MATERIAL: Serum/Vollblut; METHODE: LIA |
TCA | Trichloressigsäure i.H. | mg/l | 0.000 | - | 40.000 | MATERIAL: Spontanharn, METHODE: photometrisch |
TEICO | Teicoplanin | ug/ml | 10.00 | - | 60.00 | MATERIAL: Serum/Vollblut |
TESTOS | Testosteron | ug/l | 0.030 | - | 8.820 | MATERIAL: Serum/Vollblut, METHODE: CMIA |
TESTOSBV% | Bioverfügbares Testosteron [%] | % | - | MATERIAL: Serum/Vollblut, METHODE: Calc. | ||
TESTOSF | Testosteron (freies) | pg/ml | 0.5000 | - | 21.4800 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
TESTOSF% | Testosteron (freies) % | % | 0.6850 | - | 2.8800 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
TETQUANT | Tetanus-AK Impftiter | IU/ml | - | MATERIAL: Serum/Vollblut | ||
TFS | Transferrinsättigung | % | 2.0 | - | 45.0 | MATERIAL: Serum/Vollblut, METHODE: kalkuliert |
TGAK | Thyreoglobulin AK (TGAK) | U/ml | 0.00 | - | 115.00 | MATERIAL: Serum/Vollblut, METHODE: LIA |
THALLIUM | Thallium im Serum | ug/l | 0.00 | - | 2.00 | MATERIAL: Serum METHODE: AAS |
THALLIUMU | Thallium i.H. | ug/l | 0.00 | - | 1.50 | MATERIAL: Spontanharn METHODE: AAS |
THEO | Theophyllin | mg/l | 8.00 | - | 20.00 | MATERIAL: Serum/Vollblut, METHODE: FPIA |
THOMASPLOT | Thomas-Plot | - | ||||
THROM | Thrombozyten | G/l | 140.0 | - | 400.0 | MATERIAL: EDTA-Blut |
THROMAKFR | Thrombozyten-AK G/A/M frei | - | MATERIAL: Serum/Vollblut, METHODE: | |||
THROMAKGEB | Thrombozyten-AK gebunden | - | MATERIAL: 20ml EDTA-Vollblut, METHODE: ELISA | |||
THYREO | Thyreoglobulin | ng/ml | 0.00 | - | 77.00 | MATERIAL: Serum/Vollblut, METHODE: LIA |
TIANEPTIN | Tianeptin | ug/l | 30.0 | - | 80.0 | MATERIAL: Serum, Methode: LC-MS |
TIAPRID | Tiaprid | mg/l | 1.000 | - | 2.000 | Material: Serum/Vollblut; Methode: HPLC |
TINNITUS | BLOCK TINNITUS | - | ||||
TK | Thymidin Kinase | U/l | 2.00 | - | 7.50 | MATERIAL: Serum; Methode: RIA |
TNF | TNFa | pg/ml | 0.00 | - | 12.20 | MATERIAL: EDTA-Plasma gefroren, METHODE: LIA |
TNI | Troponin I | pg/ml | 0.00 | - | 34.20 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
TNT | Troponin T | pg/ml | 0.00 | - | 14.00 | MATERIAL: Serum/Vollblut, METHODE: MEIA |
TNTQUICK | Troponin T Schnelltest | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
TOBRA | Tobramycin | mg/l | 4.00 | - | 10.00 | MATERIAL: Serum/Vollblut; METHODE: FPIA |
TOLLWUT | Tollwut AK | IU/ml | - | MATERIAL: Serum/Vollblut METHODE: NT | ||
TOPIRA | Topiramat | ug/ml | 2.00 | - | 8.00 | MATERIAL: Vollblut/Serum |
TOX | Toxoplasmose IgG | IU/ml | - | MATERIAL: Serum/Vollblut, METHODE: ECLIA | ||
TOXAVID | Toxoplasmose IgG Avidität | - | MATERIAL: Serum/Vollblut | |||
TOXKBR | Toxoplasmose KBR | Titer | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE: KBR |
TOXM | Toxoplasmose IgM | - | MATERIAL: Serum/Vollblut, METHODE: MEIA | |||
TOXOCARAAK | Toxocara Ak | NTU | < | 11.00 | MATERIAL: Serum/Vollblut, METHODE: | |
TOXPCR | Toxoplasmose (DNA) PCR | - | MATERIAL: EDTA, METHODE: PCR | |||
TPA | TPA | U/l | 0.00 | - | 80.00 | MATERIAL: Serum/Vollblut, METHODE: CLIA |
TPBLOTG | Trep.pall.Blot IgG | - | MATERIAL: Serum; Methode: Immunoblot | |||
TPBLOTM | Trep.pall.Blot IgM | - | MATERIAL: Serum; Methode: Immunoblot | |||
TPHA | TPPA/TPHA qualitativ | - | MATERIAL: Serum/Vollblut, METHODE: Agglutination | |||
TPHAquant | TPPA/TPHA quantitativ | Titer | - | MATERIAL: Serum/Vollblut, METHODE: | ||
TPMT | Thiopurinmethyltransferase | mU/l | 100.00 | - | 200.00 | MATERIAL: EDTA-Blut; Methode: LC-MS |
TRAK | TRAK (TSH Rezeptor AK) | U/l | 0.000 | - | 1.750 | MATERIAL: Serum/Vollblut, METHODE: ECLIA |
TRAMADOL | Tramadol | ug/l | 100.0 | - | 800.0 | Material: Serum; Methode: LC-MS |
TRANS | Transferrin | mg/dl | 163.0 | - | 391.0 | MATERIAL: Serum/Vollblut, METHODE: turbidimetrisch |
TRANSCORT | Transcortin (CBG) | µg/ml | 22.0 | - | 154.0 | MATERIAL: Serum; Methode: RIA |
TRANSKETO | Transketolase | U/l | 42.0 | - | 69.0 | |
TRANSREZ | Transferrin-Rezeptor (lösl.) | mg/l | 1.050 | - | 5.000 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
TRAZO | Trazodon | ug/l | 700.00 | - | 1000.00 | MATERIAL: Serum/Vollblut METHODE: HPLC |
TREL | T-Zellen relativ | % | 60.0 | - | 85.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |
TRI | Trichlorethylen | ug/l | < | 1.00 | MATERIAL: Rollrandröhrchen (2), METHODE: GC-MS | |
TRIAZOLAM | Triazolam | ug/l | 2.0 | - | 20.0 | MATERIAL: Serum; METHODE: LC-MS |
TRICAH | Tricycl.Antidepressiva (U) | - | MATERIAL: Spontanharn; Methode: EIA | |||
TRICAS | Tricycl.Antidepressiva | - | MATERIAL: Serum; Methode: EIA | |||
TRICHIN_AK | Trichinella Ak | NTU | < | 11.00 | MATERIAL: Serum/Vollblut, METHODE: | |
TRICHOPCRU | Tri. vaginalis (PCR) i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
TRIGL | Triglyceride | mg/dl | < | 150.0 | MATERIAL: Serum/Vollblut, METHODE: photometrisch | |
TROPHWDNA | Tropheryma whipplei DNA | - | MATERIAL: EDTA, METHODE: DNA | |||
TRYP | Trypsin | ng/ml | 160.0 | - | 600.0 | MATERIAL: Serum/Vollblut |
TRYPTASE | Tryptase | ug/l | 0.00 | - | 11.00 | MATERIAL: Serum/Vollblut |
TRYPTO | L-Tryptophan | mg/dl | 0.600 | - | 1.900 | MATERIAL: EDTA-Plasma Methode: HPLC |
TSH | TSH basal | mU/l | 0.350 | - | 3.500 | MATERIAL: Serum/Vollblut, METHODE: CMIA |
TSH2 | TSH max.stimuliert | mU/l | 2.500 | - | 25.000 | MATERIAL: Serum/Vollblut, METHODE: CMIA |
TTGIGA | Tissue Transglut.IgA-Ak | U/ml | 0.00 | - | 20.00 | MATERIAL; Serum/Vollblut, METHODE: ELISA |
TTGIGG | Tissue Transglut.IgG-Ak | U/ml | 0.00 | - | 10.00 | MATERIAL; Serum/Vollblut, METHODE: ELISA |
TX1 | TX1 Bäume Mix 1 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
TX2 | TX2 Bäume (Spätbl.) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
TX5 | TX5 Bäume (Frühbl.) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
TX6 | TX6 Bäume (Spätbl.) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
TX9 | TX9 Bäume Mix 9 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
TZ | Thrombinzeit | sec | 15.0 | - | 21.0 | MATERIAL: Citrat, |
UBG | Urobilinogen | mg/dl | - | MATERIAL: Spontanharn, METHODE: STIX | ||
UBI | Ubichinon (Coenzym Q10) | ug/l | 400.0 | - | 1600.0 | MATERIAL: EDTA-Blut; METHODE: HPLC |
UBILIPKOR | Ubichinon lipidkorrigiert | > | 0.200 | MATERIAL: Serum (gefroren) METHODE: HPLC | ||
VAL | Valproinsäure | ug/ml | 50.00 | - | 100.00 | MATERIAL: Serum/Vollblut, METHODE: FPIA |
VANADKR | Vanadium /g Krea i.H. | ug/g Krea | - | MATERIAL: Spontanharn, METHODE: | ||
VANADKR_AM | Vanadium /g Krea i.H. (expon.) | ug/g Krea | 0.00 | - | 35.00 | MATERIAL: Spontanharn, METHODE:berechnet |
VANADU | Vanadium i.H.(nicht exponiert) | ug/l | 0.00 | - | 1.00 | MATERIAL: Spontanharn, METHODE: Photometrie |
VANCO | Vancomycin | ug/ml | 10.00 | - | 15.00 | MATERIAL: Serum/Vollblut; METHODE: FPIA |
VCA | Virus capsid antigen | - | ||||
VDRL | RPR/VDRL qualitativ | - | MATERIAL: Serum/Vollblut, METHODE: Agglutination | |||
VDRLquant | RPR/VDRL quantitativ | Titer | - | MATERIAL: Serum/Vollblut, METHODE: | ||
VEDOLIZU | Vedolizumab Monitoring | ug/ml | - | MATERIAL: Serum | ||
VEDOLIZUAK | Vedolizumab-AK (Entyvio) | ng/ml | 0.00 | - | 10.00 | MATERIAL: Serum |
VENLA | Venlafaxin | ng/ml | - | MATERIAL: Serum/Vollblut METHODE: LC-MS | ||
VENLA_GES | Venlafaxin+Desmeth.venlafaxin | ug/l | 100.00 | - | 400.00 | |
VGCCAKN | Ca-Kanal(VGCC)-AK (N-Typ) | Ak-RATIO | 0.000 | - | 15.000 | MATERIAL: Serum, Methode: RIA |
VGCCAKPQ | Ca-Kanal(VGCC)-AK (P/Q-Typ) | pmol/l | 0.0 | - | 30.0 | MATERIAL: Serum, Methode: RIA |
VGKCAK | Kalium Kanal-(VGKC)-AK | - | MATERIAL: Serum | |||
VIGA | Vigabatrin (Sabril) | mg/l | 2.00 | - | 10.00 | MATERIAL: Serum/Vollblut, METHODE: FPIA |
VIP | Vasoakt.Intest.Poly-Peptid | pg/ml | 0.0 | - | 70.0 | MATERIAL: EDTA-Plasma gefroren; METHODE: RIA |
VITA | Vitamin A | ug/dl | 15.00 | - | 60.00 | MATERIAL: Serum/Vollblut, METHODE: HPLC |
VITB1 | Vitamin B1,Thiaminpyrophosphat | ng/ml | 28.00 | - | 85.00 | MATERIAL: EDTA-Blut, METHODE: HPLC |
VITB12 | Vitamin B12 | pg/ml | 197.0 | - | 771.0 | MATERIAL: Serum/Vollblut, METHODE: CMIA |
VITB2 | Vitamin B2, FAD | ng/ml | 180.00 | - | 295.00 | MATERIAL: EDTA-Blut, METHODE: HPLC |
VITB3 | Vitamin B3 (Nicotinamid) | ug/l | 8.00 | - | 52.00 | MATERIAL: Vollblut/Serum |
VITB5 | Vitamin B5 (Pantothensäure) | ug/l | 21.00 | - | 104.00 | MATERIAL: Serum, METHODE: HPLC |
VITB6PLP | Vitamin B6, PLP | ug/l | 8.60 | - | 27.20 | MATERIAL: EDTA-Blut, METHODE: HPLC |
VITC | Vitamin C | ug/ml | 2.000 | - | 14.000 | MATERIAL: Serum/Vollblut, METHODE: HPLC |
VITD | Vitamin D (25-OH) | ng/ml | 30.000 | - | 100.000 | MATERIAL: Serum/Vollblut, METHODE: CLIA |
VITD2 | Vitamin D2-(25-OH) | ng/ml | - | MATERIAL: Serum/Vollblut, METHODE: HPLC | ||
VITD3 | Vitamin D3(1,25-(OH)2) | ng/l | 19.900 | - | 79.300 | MATERIAL: Serum/Vollblut, METHODE: CLIA |
VITDFREI | freies Vitamin D (25-OH) | pg/ml | 8.49 | - | 28.30 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
VITE | Vitamin E | ug/dl | 100.00 | - | 1800.00 | MATERIAL: Serum/Vollblut, METHODE: HPLC |
VITH | Vitamin H (Biotin) | ng/l | > | 250.00 | MATERIAL: Serum gefr.; Methode: EIA | |
VITK | Vitamin K1 | ng/l | 110.00 | - | 2280.00 | MATERIAL: 2ml Serum, METHODE: HPLC |
VITK2 | Vitamin K2 - MK4 und MK7 | - | Material: 2ml Serum gefroren METHODE: | |||
VITK2MK4 | Vitamin K2 (Menachinon-4) | ng/l | 330.0 | - | 1780.0 | MATERIAL: 2ml Serum gefroren+lichtgeschützt |
VITK2MK7 | Vitamin K2 (Menachinon-7) | ng/l | < | 500.0 | MATERIAL: 2ml Serum gefroren+lichtgeschützt | |
VLCFA | Ultra-Langkettige Fettsäuren | - | Methode: GC/MS | |||
VMS | Vanillinmandelsäure i.24h H. | mg/24h | 1.60 | - | 7.30 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
VORTIOX | Vortioxetin | ug/l | 10.0 | - | 50.0 | MATERIAL: Serum/Vollblut |
VWF | VWF-Antigen | % | 58.00 | - | 174.00 | MATERIAL: Citrat, METHODE: koagulometrisch |
VWFAKT | VWF-GPIb-Aktivität | % | 48.00 | - | 173.00 | MATERIAL: Citrat, METHODE: koagulometrisch |
VWFQ | VWF-GPIb-Ratio | 0.70 | - | 1.50 | MATERIAL: Citrat, METHODE: koagulometrisch | |
VZV | Var.-Zoster IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | |||
VZVM | Var.-Zoster IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
VZVPCR | VZV-Virus DNA (PCR) | - | MATERIAL: EDTA, METHODE: PCR | |||
VZVQUANT | Var.-Zoster IgG Impftiter | U/ml | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | ||
W1 | W1 Hohe Ambrosie | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W10 | W10 W.Gänsefuß | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W12 | W12 Goldrute | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W18 | W18 Sauerampfer | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W19 | W19 Parietaria officin. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W2 | W2 Ragweed | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W20 | W20 Brennessel | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W203 | W203 Raps | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W206 | W206 Kamille | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W207 | W207 Lupine | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W21 | W21 Parietaria judaica | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W230 | W230 nAmb a 1 Ambrosie | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W231 | W231 nArt v 1 Beifuß | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W233 | W233 nArt v 3 Beifuß | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W3 | W3 Ambrosie, dreilappig | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W4 | W4 falsche Ambrosie | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W5 | W5 Wermut | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W52 | W52 Arnika | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W6 | W6 Beifuß | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W7 | W7 Margarite | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W8 | W8 Löwenzahn | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
W9 | W9 Spitzwegerich | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
WBB | Weißes Blutbild | - | MATERIAL: EDTA | |||
WEBSTER | Trinitrotoluol n. Webster i.H. | - | MATERIAL: Harn, | |||
WNVG | West-Nil-Virus IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
WNVM | West-Nil-Virus IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
WNVPCR | West-Nil-Virus RNA | - | MATERIAL: Serum/Vollblut, METHODE: RT-PCR | |||
WX1 | WX1 Kräuterpollen 1 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
WX3 | WX3 Kräuterpollen 3 | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
XA1MGUKR | Alpha-1-Mikroglob. /g Krea i.H. | mg/g Krea. | 0.00 | - | 14.00 | XMATERIAL: Spontanharn, METHODE: Turbitimetrisch |
YERAG | Yersinien Erregernachweis | - | MATERIAL: Stuhl | |||
YERKULT | Yersinien Kultur | - | MATERIAL: Stuhl, METHODE: Kultur | |||
YERO3 | Yers.enterocol. 03 Widal | Titer | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
YERO9 | Yers.enterocol. 09 Widal | Titer | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE:ELISA |
YERPS | Yers.pseudotub. | Titer | 0.0 | - | 40.0 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
ZECKENBISS | BLOCK ZECKENBISS | - | ||||
ZIKAPCR | Zikavirus (RNA) PCR | - | MATERIAL: EDTA, METHODE: PCR | |||
ZINK | Zink | umol/l | 6.70 | - | 18.40 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
ZINKERY | Zink im Erythrozyten | mg/l Ery | 8.80 | - | 16.00 | MATERIAL: EDTA, METHODE: AAS |
ZINKU | Zink /g Krea i.H. | µg/g Krea | 2000.00 | - | 9000.00 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
ZINKV | Zink im Vollblut (EDTA) | mg/l | 4.00 | - | 7.50 | MATERIAL: EDTA, METHODE: AAS |
ZIPRASIDO | Ziprasidon | ug/l | 50.0 | - | 200.0 | MATERIAL: Serum/Vollblut METHODE: LC-MS |
ZM51 | P-AK: Thermopolyspora polysp. | mg/l | 0.000 | - | 30.000 | MATERIAL: Serum, METHODE: ELISA |
ZnT8AK | Zink-Transporter 8 AK | U/ml | 0.00 | - | 15.00 | MATERIAL: Serum, METHODE: EIA |
ZOLPIDEM | Zolpidem | ug/l | 80.0 | - | 160.0 | MATERIAL: Serum, METHODE: LC-MS |
ZONISAMID | Zonisamid | ug/ml | 10.00 | - | 40.00 | MATERIAL: Serum/Vollblut, METHODE:LC-MS |
ZONU | Zonulin im Serum | ng/ml | 0.000 | - | 48.000 | MATERIAL: Serum; Methode: EIA |
ZONUST | Zonulin i.St. | ng/ml | 0.000 | - | 55.000 | MATERIAL: Stuhl; Methode: EIA |
ZOPICLON | Zopiclon | ug/l | 55.0 | - | 85.0 | MATERIAL: Serum, METHODE: LC-MS |
ZOTEPIN | Zotepin | ng/ml | 10.00 | - | 120.00 | MATERIAL: Serum/Vollblut METHODE: |
ZPP | Zink-Protoporphyrin | ug/g(Hb) | 0.7000 | - | 4.0000 | MATERIAL: EDTA-Blut, METHODE: fluorimetrisch |
ZUCLO | Zuclopenthixol | ng/ml | 4.00 | - | 50.00 | MATERIAL: Serum/Vollblut METHODE: GC-MS |
ZYTO | Zytologie i.H. | - | MATERIAL: Harn/Punktat |